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 Chapter One 
Introduction 
ADHD Overview 
The most recent edition of the Diagnostic and Statistical Manual of Mental 
Disorders (DSM-IV-TR, 2000) provides the presently-accepted nosology of psychiatric 
and personality disorders that modern healthcare providers use for diagnosis.   The 
present edition characterizes Attention Deficit Hyperactivity Disorder (ADHD) as a 
disorder first apparent in childhood; current diagnostic criteria require that 
developmentally inappropriate symptoms of inattention or disinhibition, hyperactivity, 
and impulsivity (depending on subtype) not only persist for at least 6 months, but have 
been present since before the age of seven.  Although that age was chosen somewhat 
arbitrarily according to supporters and critics alike (Gordon & Murphy, 1998), it is 
generally accepted that the problematic nature of these symptoms first emerges in the 
early school years (see Barkley, 2006).  Researchers theorize that the early onset is 
attributable to a number of causes, including genetic neurodevelopmental or 
organizational problems, or early structural damage to the fronto-subcortical circuit 
(Powell & Voeller, 2004; Swanson & Castellanos, 2002) affecting appropriate acquisition 
of essential cognitive, behavioral, and emotional regulatory behaviors.  Numerous 
structural and functional neuroimaging studies exist to support the presence of such 
damage in diagnosed youngsters (see Dickstein, Bannon, Castellanos, & Milham [2006] 
for a meta-analytic review of the literature).  Of course, later ADHD onset is possible, 
secondary to acquired neurological damage, but at this time there is no DSM-IV category 
for this condition. 
The Impact of ADHD in Educational Settings 
Regardless of the specific cause or age of onset of attentional impairment, it is 
clear that ADHD-characteristic dysfunction may be associated with significant 
impairment in educational, occupational, and interpersonal functioning as a result of the 
cognitive, behavioral, and emotional difficulties arising from ADHD.  Thus, individuals 
with the syndrome or disorder have the potential to be significantly disabled, requiring 
special accommodations in educational settings.  The myriad possible causes of such 
impairment are reflected in substantial base rates of diagnosed ADHD—ranging from 7-
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 12% of the elementary through high school-aged population, based upon an 
epidemiological study conducted by the US Centers for Disease Control in 2003 (see 
Biederman, 2005)—to estimates of 27% of adults,1 including undiagnosed cases (see 
Goldstein, 2006).  Even at the more conservative estimates, which do not include those 
young Americans for whom evaluation was out of reach due to economic, cultural, 
parental, or other reasons, this leaves a great number who may require special 
accommodations in their educational and occupational endeavors.   
When tightening the focus of ADHD-affected individuals to college or university 
students, it becomes even more difficult to cite a base rate with confidence.  Evidence 
exists that the syndrome may be "outgrown," and particularly that hyperactive symptoms 
may remit (see Shaw, 2000, for a review; see also Biederman, Farone, Milberger, Curtis, 
et al., 1996).  However, prevalence estimates for adults with ADHD vary widely.  
Barkley and Murphy (1998) estimated that 60% of childhood-onset patients experience 
persistent ADHD.  A meta-analytic review of the literature conducted by Farone, 
Biederman, & Mick (2006), provides evidence that only 15% of individuals diagnosed in 
childhood met full DSM-IV criteria by age 25, with 65% meeting criteria for ADHD "in 
partial remission."  Of note, these estimates do not include adult-onset cases lacking 
evidence for the disorder in childhood, or "Adult ADHD," as it is termed in today's 
media. In addition to statistical evidence for the resolution of some cases of ADHD, 
biological and theoretical reasons for recovery can be derived from examination of the 
acquired brain injury literature: Dendritic growth may occur, as evidenced in human and 
other mammalian TBI and stroke research (see Chen, Atkins, Liu, Alonso, Dietrich, & 
Hu, 2007 for an in-depth review; Scheff, Price, Hicks, Baldwin, Robinson, & Brackney, 
2005), and individuals may develop compensatory strategies, as demonstrated in 
cognitive rehabilitation literature (e.g., Yongue, 2006; Verne, Mezzanato, & Caminti, 
2006; Mooney, Speed, & Shepard, 2005; Rath, Simon, Langenbahn, Sherr, & Diller, 
2003).  Moreover, the acquisition of the necessary cognitive, behavioral, and emotional 
skills impaired in childhood-onset ADHD may be grossly slowed or delayed, rather than 
thwarted altogether, for a portion of the affected.   
                                                 
1 This is an estimate based upon US Census data provided in wikipedia.org, using the estimated 8 million 
adults referenced in Goldstein (2006).  The estimate was derived from DSM-IV symptom telephone 
surveys of 2.4 million US residents conducted by a Fortune-500 medical company (note conflict of 
interest).   
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 Despite the challenges in establishing a reliable base rate of ADHD in college-
aged population, determining such is highly important for two reasons.  First, it may 
serve as a "check" for the integrity of an individual clinician's use of the diagnosis.   
Second, it may serve as a signal for other phenomena, such as in the presence of 
abnormally high local base rates or temporal increases in a base rate.  For example, a rise 
in current ADHD diagnoses from 2% to 20% of a university's medical school 
population—a group for which high rates of lifelong impairment associated with ADHD 
are unlikely—might indicate the growing popularity of seeking psychostimulant 
medication.   Indeed, a gross increase in the rate of adults, including college students, 
seeking ADHD diagnostic evaluations has recently been evidenced (see Harrison, 2006).  
Gordon and Murphy (1998) state that most institutions and testing organizations reported 
at least a doubling of ADHD-based claims in the mid-to-late 1990s.  Many of these 
individuals were unable to provide adequate childhood histories or any evidence of 
lifelong impairment (Harrison, 2006).  This raises concern that an ADHD diagnosis is 
being considered by at least some of these adult evaluees for the first time, and questions 
as to why that may be direct attention to an issue of growing significance in university 
settings.   
Diagnostic Incentives in University Settings 
Significant motivations and incentives exist for seeking a diagnosis of ADHD—
accurate or not—in North American higher education facilities.  For one, the Americans 
with Disabilities Act (ADA; 1990, PL 101-336) established that individuals with 
cognitive and psychiatric disabilities, relative to the general population, may be eligible 
for special accommodations.  The ADA does not provide for otherwise unqualified 
students to be granted an equal opportunity to those meeting the academic and technical 
standards of a course or program (Keiser, 1998).  Instead it calls for  the establishment of 
"Reasonable Accommodations." 
Although a structured algorithm for the nature and degree of accommodations that 
should be provided by educational facilities is not available, these typically involve 
assistance "taking in the educational nourishment" (Keiser, 1998; p. 46) and receiving 
fair evaluations, when applied to ADHD-diagnosed students (Keiser, 1998).  McGuire 
(1998) provides a list of common accommodations in such cases, which includes extra 
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 time for written work and tests, no spelling penalty, selective seating, electronic aides 
including tape recorders, reduced homework, availability of teacher notes, clarification of 
directions and questions for assignments and exams when a student apparently does not 
understand, and re-examination where re-teaching has been indicated.   Because 
pharmacotherapy is not considered an ADA accommodation despite the fact that it almost 
always "wins" in head-to-head comparisons with non-medical interventions by producing 
more positive effects in a shorter period of time (see Gordon & Murphy, 1998); and 
because research has not indicated consistently efficacious environmental interventions 
for ADHD students, meeting the ADA guideline of providing "Reasonable 
Accommodations" for students with ADHD is difficult.  Some universities have chosen 
liberal approaches to this, perhaps to avoid legal ramifications.  Both Harrison (2006) and 
Jachimowiz and Geiselman (2004) give example accommodations, which extend far 
beyond extra test time to include free computers, free tutoring services, private dormitory 
rooms, and significant amounts of financial support.  Separate testing rooms may also be 
provided in many schools, and although this has not been stated outright, this may be 
appealing to students inclined to cheat.   
Jachimowiz and Geiselman (2004) comment that services and supports like those 
described above are not only a great help to students with disabilities, but would be 
equally helpful to those without disabilities.  They further state that in today's job market, 
enhancing college performance is helpful to secure employment or to improve chances of 
attaining admission to graduate programs that may further increase odds of later career 
and financial success.  Based upon these notions, it is no surprise that undergraduates 
may be consciously or unconsciously motivated to be diagnosed with ADHD.  This is 
only a part of the picture, however.   
Beyond the ADA accommodations lies another potentially powerful incentive for 
students to desire an ADHD diagnosis: psychostimulant medications.  Just like steroids 
may benefit the performance of most athletes, psychostimulants have the potential to 
assist students regardless of the presence or absence of attentional dysfunction.  
Stimulants work by enhancing catecholamine activity and probably by increasing the 
availability of norepinephrine and dopamine at the synaptic cleft (see Solanto, 1998, in 
Connor, 2006).  The result is enhanced neurotransmission and a corresponding increase 
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 in blood flow to the frontal and parietal lobes.  In turn, responders experience improved 
attention and concentration, processing speed, and consequently better learning and 
memory (see Connor, 2006, for a review of cognitive, learning, and academic 
improvements).  Stimulants may decrease required studying time, freeing more time for 
socialization or other activities and result in better outcomes such as grades.  They do not, 
however, appear to significantly enhance performance on intellectual testing (Rapport & 
Kelly, 1991, in Connor, 2006). 
In addition to potentially improving academic functioning, psychostimulants may 
be sought by students for recreational purposes.  As with cocaine, prescription stimulants, 
when inhaled or injected, cause a sense of euphoria.  Mixing methylphenidate in 
particular with large quantities of alcohol is said to enhance this euphoria while 
diminishing the subjective sense of "drunkenness" (Barrett & Phil, 2002, in Harrison, 
2006).   Conti (2004) states that there is no better way to obtain a psychostimulant high 
than legally, particularly when the prescription may be subsidized! 
 Evidence for both the recreational and academic misuse of prescription stimulants 
is found throughout the literature.  Several studies have reported a nation-wide increase in 
psychostimulant prescriptions during recent years (see Olfson, 2003; Robison, 2002), and 
multiple surveys have provided evidence of misuse at the university level.  In a survey of 
1,025 Northeastern US university students, 16% endorsed misuse or abuse of prescription 
stimulants, with reported motivations of improving attention and grades (White, Becker-
Blease, & Grace-Bishop, 2006).  A survey of 10,904 randomly selected college students 
identified a 6.7% prevalence of non-medical prescription stimulant use, 4.1% in the past 
year, and 2.1% in the past month (McCabe, Knight, Teter, & Wechsler , 2005).  
Likewise, an investigation of past-year illicit methylphenidate use in 2,250 
undergraduates found a base rate of 3% (McCabe, Teter, Boyd, & Guthrie, 2003).    
Identifying "Genuine" DSM-IV ADHD 
 Considering the information provided above, it becomes apparent that college 
students have significant incentive to seek ADHD diagnosis and treatment, even when 
they may know they do not require it.  Unfortunately, little research exists today on how 
best to identify genuine ADHD cases, while limiting misdiagnoses.   
Arriving at a diagnosis of DSM-IV-defined ADHD is not simple.  A sound  
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 determination requires ruling out multiple symptomatically similar conditions including 
learning disabilities, psychiatric disorders such as anxiety, depression, bipolar disorder, 
and early psychotic spectrum disorders—a process that involves conducting a very 
detailed clinical interview, obtaining an adequate history with corroborating evidence, 
and completing neuropsychological testing (see Gordon & Murphy, 1998).  In addition, 
diagnosis requires establishing that clinically significant levels of impairment are 
currently present in social, academic, or occupational settings (see Hagar & Goldstein, 
2005, for a discussion of "clinical significance" in undergraduate diagnoses); confirming 
that evidence for impairment exists in at least two settings (such as home and class); and 
perhaps most importantly, identifying evidence that impairment existed during childhood.   
Lastly, when external incentives such as disability accommodations, study-
enhancing medications, and stimulant "highs" are available, the possibility exists that 
individuals without ADHD may deliberately try to be diagnosed (i.e., malinger) or sub-
consciously convince themselves (and in the process, others) of the disorder's presence.  
If possible, clinicians should try to assess the legitimacy of symptoms, including self-
presentation on both subjective symptom reports and symptom-related test performance. 
 This directs attention to two caveats.  First, the complexity of this evaluative 
process is riddled with weaknesses in tests' diagnostic accuracies and abilities to predict 
levels of impairment in everyday life.  Unfortunately, there are no neuropsychological or 
symptom report tests sensitive or specific enough to both ADHD and its rule-out 
conditions to significantly facilitate this process (see Barkley, 2006; Gordon & Murphy, 
1998). Computerized tests of impulsivity and attention have only fair sensitivity to the 
condition (Homack & Reynolds, 2006), poor specificity to differentiate ADHD from 
symptomatically similar conditions (Quinn, 2003; Homack & Reynolds, 2006), and poor 
convergence with other measures (Homack & Reynolds, 2006).  Self-report measures of 
current or childhood symptoms are prone to over-identifying students and adults as 
having ADHD when they do not—in addition to being insensitive to true ADHD 
(Harrison, 2006; McCann & Roy-Byrne, 2006).   
The second caveat is that very little empirical evidence exists as to the sensitivity 
and susceptibility of self-report, standard neuropsychological, or feigning tools to 
exaggerated or faked ADHD.  The symptom-report measures and computerized 
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 continuous performance tests, including those with validity scales, have not routinely 
been assessed for their robustness to faking.  With one exception, stand-alone 
neurocognitive feigning tools have not been evaluated in studies of feigned ADHD.  
Instead, evaluations of neurocognitive feigning measures have most commonly been 
conducted in genuinely and allegedly brain-injured samples claiming disability levels 
warranting unemployment.  It cannot be assumed that such measures will generalize to a 
likely higher-functioning population such as that of college students claiming a relatively 
partial disability.  An evaluative review of the existing literature is provided below. 
Previous Undergraduate ADHD Feigning Studies
 At this time, only a handful of studies have evaluated one or more measures 
employed in the diagnosis of ADHD, for susceptibility to feigning using a simulation 
paradigm in an undergraduate sample.  None of these are known-groups evaluations.  
Table 1-1 provides a summary of each study's methodology, including demographic 
makeup and specific instruction sets. Study results are provided in Table 1-2, in the form 
of Hedges’ g effect size parameter, (a Cohen’s d equivalent corrected for small sample 
size), and are discussed later.   
 Methodologies   
As can be seen in Table 1-1, the few available studies identified lack consistency 
in measures, research goal, and methodological rigor.  Only three included an ADHD-
diagnosed clinical control group.  The majority of studies provided feigners with a 
scenario that may help them relate to their role, information about the nature and 
symptomatology of ADHD, and an admonition to feign believably.  At face value, these 
are strengths of the studies.  However, no study with a clinical control group demon-
strated diagnostic consistency, or more importantly, diagnostic certainty on an individual 
level.  For example, Quinn's (2003) ADHD group was "diagnosed" using only a clinical 
interview and symptom report measure.  Similarly, Harrison's (2007) clinical group was 
identified using only a symptom-report measure and an achievement test.  The Booksh 
study (2005) ADHD group did not undergo a rule-out of psychiatric disorders that may 
mimic ADHD.  In addition to addressing these weaknesses, it can be argued that simple 
procedures may be added to greatly enhance the ecological validity of ADHD feigning 
studies.  This is discussed in greater detail below. 
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 Table 1-1   
 
Summary of Undergraduate ADHD Feigning Study Characteristics for those Involving a Simulation Group 
First 
Author 
Study 
Design 
Grou
p 
Recruit  
From N 
M(SD)
 
Age 
% 
Male 
M(SD) 
 
IQ est 
IQ 
Source 
comp/ 
inc 
mal
warn 
scen-
ario 
Preparatory Procedures 
and Measures 
Order of 
Test 
Booksh Sim HON PSY 54 - n/a cc   
  MAL PSY 55 
20.4 
(2.1) 20% - n/a cc, $50 raffle Y (1) 
WAIS-III selections, 
Connors' CPT,  
WURS, MINI, WMT, 
Rey FIT 
1. Effort 
m  2. Rest, 
random-
ized. 
  ADHD 
archive, 
Univ 
AC 
56 21.1 (3.1) 30% - n/a n/a   
Some overlap with 
above Unknown 
              
Fisher 
Othera MAL PSY 88 
    87 
19.6 
(2.0) 19% - n/a 
cc, $25 
raffle Y (2) 
Read DSM-IV criteria 
then asked to fake on 
one measure: CARE or 
ARS 
Only one 
test admin 
to each 
group 
 
Harrison Sim HON PSY 35 105.8 (6.6) NAART cc   
  MAL PSY 35 
18.7 
(1.11) 36% 106.9 
(6.5) NAART cc Y (3) 
NAART; instructions; 
then CAARS; WJ-III 
Rdg Flu, Vis Matching 
& Decision Speed 
As listed 
  
 
ADH
D 
 
archive, 
Univ 
AC 
 
72 
 
22.9 
(7.0) 
 
46% 
 
106.7 
(12.0) 
 
WAIS-III 
 
0   Met DSM-IV criteria 
& Bush (2005) criteria 
for symptom validity 
assessment in absence 
of formal assessmenta 
CAARS, WAIS-III. 
 
Unknown 
 
Jachi-
mowitz Other
a MAL PSY 20 - - - n/a cc N N 
Read DSM-IV criteria 
then asked to fake on 
one measure: CAARS 
WURS, BAAS or ARS 
Only one 
test admin 
to each 
group 
 
8 
 8 
 Leark H-M PSY 18 - Y 
 
Sim 
w/in M-H PSY 18 
22.4 
(2.4) 44% - n/a - Y 
(4) Coached.  TOVA only.  n/a 
 
Quinn Sim HON PSY 19 - - - n/a -   
  MAL PSY 23 - - - n/a - N (2) 
IVA-CPT, Barkley-
Murphy ADHD 
Symptom Checklist 
Random-
ized 
 ADH
D 
Univ 
DO  16 - - - n/a -   
Interview, self-rpt, 
some with IVA-CPT Unknown 
Note.  See Table 1-2 for a summary of applicable results.  Where demographic cells are combined, this is merely how data were presented in the 
study and does not imply that there was no group difference.  cc = course credit, comp/inc = compensation or incentive, DP = differential 
prevalence or correlational design (correlate test failure with performance on other measures), H-M = honest condition first then malingering 
condition, m=measure, M-H=malingering condition first then honest condition, n/a=not applicable, PSY = Introductory Psychology course, Univ 
AC = university assessment center, Univ DO = university Students with Disabilities Office, scenario=feigning scenario (listed below), warn = 
admonition to feign believably, w/in = within subjects design. 
 
Feigning Scenarios: 
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(1)  "Imagine that you have significant problems with inattention, impulsivity, and/or hyperactivity that are interfering with your academic 
performance.  You believe that if you are diagnosed with ADHD you may be given some academic accommodations, such as extended time for 
tests, or medication, such as Ritalin, that will improve your grades.  Your job in this experiment is to successfully convince the experimenter that 
you have ADHD, so you want to perform on these tests as if you actually have ADHD.  Some of the tests you will take contain validity measures 
of effort and honesty that indicate whether you are putting forth good effort.  You want to fool the experimenter, that is, you want it to look as if 
you have ADHD, without arousing any suspicion.  You should appear to be putting forth a good effort.  Participants that successfully simulate 
ADHD and have acceptable validity scores will be entered in a drawing at the end of the semester for a $50 gift certificate to a local restaurant." 
 
(2)  "Imagine yourself having trouble in school. Things aren't working out as you planned but your counselor's only advice is to work harder. 
You want to get some help.  You hear about adult ADHD on a television show.  When talking to a friend about it, your friend tells you that you 
could get special accommodations from the university, like untimed tests and rescheduling of exams if two are given on the same day.  Your 
friend ADHDs that the stimulant medications that are generally prescribed have minimal side effects and that you can take the medicine only 
when you need it, just for school.  You decide to read a book on ADHD.  You find out that some ADHD adults even collect social security 
benefits.  You conclude that you have enough of the symptoms.  You convince yourself that you have ADHD.  You go to the doctor and you 
really want to get help.  In order to get these benefits, you need to convincingly act like a person who has ADHD." 
 
(3)  "We would like you to complete these tests as if you were pretending to have an attention deficit disorder (ADHD).  Imagine that you have 
heard about academic accommodations and other "perks" that are offered to people with this disability, and that you are trying to pretend that 
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 you have this condition.  You have heard that people who have this diagnosis get extra time for tests and exams, and can access money to 
purchase computers and other equipment.  When you research ADHD on the internet, you find the following diagnostic criteria (see below)." 
(DSM-IV criteria provided).  "Please complete the following tests as if those characteristics apply to you.  It is important, however, that you not 
be caught in your efforts to exaggerate, so make sure your performance is believable."   
(4) "I want you to take this test in such a way as to show me that you have ADHD when indeed you may not have ADHD.  That is, try to make 
yourself appear as if you have a problem with attention and impulse control, even though you do not.  In other words, fake bad on the test, but try 
not to be too obvious about your faking.  
 
a Only contained feigning participants, each group administered a different measure (N reflects group size).
10 
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 As a whole, the methodologies of the identified feigning studies do not begin to 
compare in rigor to the research on feigned cognitive impairment (see Sollman & Berry, 
under review, for a comparison).  Methodological weaknesses include the fact that only 
two studies reported providing simulators with incentive beyond course credit (Booksh, 
2005; Fisher, 2007).  Rogers (1997) cautions researchers that adequate incentives are 
necessary in the assessment of simulated malingering in order to approximate real-world 
conditions and to assure participants' motivation to feign.  Additionally, only one study 
utilized a number and variety of diagnostic tests that would approximate a real-world 
evaluation, including standard neuropsychological measures (Booksh, 2005).  Only one 
study reported group IQ estimates, which are helpful for understanding the success of 
feigning group and for comparing results between studies.   
The most notable weakness in the evaluations is that only one study (Booksh, 
2005) included a standard neurocognitive feigning measure.  These are commonly 
employed in evaluations of suspected or feigned neurocognitive impairment, which is 
often associated with impulsivity and attentional difficulties that may mimic ADHD.  
Theoretically, therefore, neurocognitive feigning measures may be helpful in the detection 
of  feigned ADHD.  The Booksh study (2005) employed the Word Memory Test (Green, 
2000), and found that it separated feigning and honest groups well (mean d-metric = 1.6) 
and demonstrated superb specificity to rule out feigning in honest individuals (1.0).  
However, the measure demonstrated only moderate sensitivity (.58).   No studies 
evaluated included psychiatric feigning indices which are frequently employed in 
correctional and inpatient psychiatric settings.   
Summary of Previous Studies’ Results 
Having examined the methodologies of studies to date, a summary of the studies’  
results ensues.  These are provided for computerized measures of impulsivity and 
attention (continuous performance tests [CPTs]), and symptom report tests in general.  
Due to the number of measures examined and the differences in types of scores provided, 
a quantitative summary of results across studies is generally not possible.  However, 
selected data are provided in Table 1-2. 
CPTs. The Conners' CPT and the Integrated Visual and Auditory CPT (IVA-CPT) 
were evaluated separately within two of the five above-mentioned ADHD feigning  
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 Table 1-2 
 
Results of Previous Simulation Studies Pertinent to the Present Dissertation's Proposed Measures  
 
 
Results (M [SD]) Effect Size (g ) Test Parameters 
       
  
 
HON MAL CLIN 
Hon-
Clin 
Mal-
Clin 
Hon- 
Mal Sn Sp 
         
BOOKSH DISSERTATION (2005)         
Connors' CPT         
     Commission Errors 51.4 (11.2) 66.1 (13.5) 66.4 (14.7) 1.1 0.1 1.2 n/a n/a 
     Omission Errors - - - - - - n/a n/a 
     Hit Rate 54.5 (10.7) 52.3 (15.1) 52.2 (10.4) -0.2 0.0 0.2 n/a n/a 
     Hit Rate Standard Error 59.2 (13.5) 81.7 (25.1) 67.2 (14.7) 0.6 0.7 1.1 n/a n/a 
     Hit Rate Variability of Standard Error 52.8 (10.3) 72.1 (16.9) 62.4 (11.6) 0.9 0.7 1.4 n/a n/a 
         
        FISHER DISSERTATION (2007) 12 
Barkley-Murphy ARS          
Current Sympt  oms         
  Inattentive Total n/a 77%  faked n/a n/a n/a n/a - n/a 
  Hyperactive Total n/a 5.8 (2.4) n/a n/a n/a n/a - n/a 
  Inattentive Symptoms n/a 5.1(2.6) n/a n/a n/a n/a - n/a 
  Inattentive Total n/a 11.0 (2.8) n/a n/a n/a n/a - n/a 
         
        HARRISON (2007) 
CAARS (see note below)         
     Inattention/Memory Problems - - - 1.2 0.4 - - - 
     Hyperactivity/Restlessness - - - 1.4 0.8 - - - 
     Impulsivity/Emotional Labiality - - - 0.8 0.8 - - - 
     Problems with Self-Concept - - - 0.7 0.3 - - - 
     DSM-IV Inattentive Symptoms - - - 1.5 0.7 - - - 
     DSM-IV Hyperactive/Impulsive Sympt - - - 1.1 1.3 - - - 
     DSM-IV ADHD Symptoms Total - - - 1.4 1.1 - - - 
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      ADHD Index - - - 1.0 0.9 - - - 
         
        JACHIMOWICZ  & GEISELMAN (2004) 
Barkley-Murphy ARS n/a 75%  faked n/a n/a n/a n/a 0.3 n/a 
CAARS—S:L n/a 90%  faked n/a n/a n/a n/a 0.1 n/a 
         
QUINN (2003)         
Barkley-Murphy ARS         
Retrospective Symptoms         
  Inattentive Total 6.9 (5.2) 18.7 (5.6) 19.8 (4.4) 2.7 -.2 2.1 - - 
  Hyperactive Total 6.7 (5.1) 18.8 (6.1) 18.0 (5.3) 2.1 .1 2.1 - - 
  Inattentive Symptoms 1.8 (2.5) 6.8 (2.5) 7.2 (1.7) 2.4 -.2 2.0 - - 
  Hyperactive Symptoms 1.9 (2.1) 6.5 (2.4) 6.6 (2.2) 2.1 -.0 2.0 - - 
Current Symptoms       .7a .4 a13   Inattentive Total 4.9 (3.6) 17.9 (5.5) 14.7 (4.7) 2.3 .6 2.7 .8 .6 
  Hyperactive Total 5.3 (3.4) 15.5 (5.6) 14.4 (5.3) 2.0 .2 2.1 .7 .4 
  Inattentive Symptoms 0.7 (1.2) 6.4 (2.6) 4.9 (2.4) 2.2 .6 2.7 n/a n/a 
  Hyperactive Symptoms 0.8 (1.1) 5.4 (2.5) 4.8 (2.2) 2.2 .3 2.3 n/a n/a 
         
 
Note. In Harrison study, the MAL group obtained T- scores higher than the CLIN group on the CAARS.  Raising the cut score to 70T created 
more of a disparity between the three groups, and increased Specificity for the Hon group.  Also, in the Harrison study, students were not 
instructed to think of themselves "off of medications" when reporting on the CAARS.  In the Quinn study, the ADHD group did not score in the 
ADHD range on the Barkley Murphy ADHD Rating Scale's Current symptoms scale.  Also, there was no significant difference between the 
clinical and malingering group on Childhood symptoms scale; thus, malingerers were not discriminated.    CLIN = clinical group, HON = honest 
group, n/a = not applicable, MAL = feigning group, - = missing, Sn = sensitivity to actual ADHD, Sp = specificity.  
a Combined Subtype parameters: Using the criteria of >6 Inattentive items ranked 2 or 3, and > 6 Hyperactive items ranked 2 or 3.  b Inattentive 
Subtype parameters: Using the criteria of > 6 Inattentive items ranked 2 or 3.  c Hyperactive Subtype parameters: Using the criteria of >5 
Hyperactive symptoms ranked 2 or 3. 
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 studies.  Both tests separated normal honest and ADHD groups on at least one index 
(IVA-CPT Full Attention Quotient d-metric = 1.1 [Quinn, 2003], C-CPT Commission 
Errors d-metric = 1.2 [Booksh, 2005]).  The clinical group was accurately identified 86% 
of the time in the Quinn study, using three different scoring algorithms.  However, it must 
be noted that this does not point to the measures' true sensitivity to ADHD, as other 
diagnostic conditions were not ruled out in either study.   
The separation of the feigning and ADHD groups across CPTs was less 
successful.  Only the IVA-CPT, as evaluated by Quinn (2003) appeared to be somewhat 
resilient to feigning.  The Full Attention Quotient of the IVA-CPT yielded a d-metric of 
1.9, whereas the best C-CPT T-score mean yielded a d-metric of 0.7.  The IVA-CPT was 
not successfully faked on 81% of its scales according to the author.  A mean sensitivity to 
feigning of .86 was found for the IVA-CPT across three scoring algorithms.  
Self-Report Symptom Questionnaires.  Examining results across studies, 
symptom report tests generally discriminated normal honest groups from both feigning 
and ADHD groups. However, these measures demonstrated inadequacy in separating 
feigned ADHD from diagnosed ADHD.   
The Booksh (2005) study employed two symptom-report measures, the Wender 
Utah Rating Scale (WURS) to assess historical (childhood) symptomatology, and the 
Attention-Deficit Scale for Adults (ADSA) to assess current symptomatology.  These 
discriminated feigned and diagnosed ADHD profiles with variable success in this study 
(WURS d-metric = .5, ADSA d-metric = 1.1).  Test parameters could not be calculated 
due to a lack of information.  The Quinn (2003) study employed the Retrospective 
(childhood) and Current Symptom indices of the Murphy and Barkley ADHD Rating 
Scales.  Neither of these robustly separated feigned from diagnosed ADHD profiles, with 
d-metrics ranging from 0 to .6.  Harrison (2007) examined the Conners Adult ADHD 
Rating Scale (CAARS) and demonstrated slightly more promising results, effect size 
estimates ranging from 0.3 to 1.2.  Both the ADHD Total Symptoms Index (d –metric = 
1.1) and the ADHD Hyperactive/Inattentive Symptoms Index (d-metric = 1.2) separated 
simulated and diagnosed ADHD profiles somewhat adequately, in that study.  Neither 
Quinn (2003) nor Harrison (2007) provided data allowing for the calculation of test 
parameters.   
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 Lastly, in the Jachimowicz and Geiselman (2004) study, students produced 
profiles "consistent with ADHD" on the Brown ADHD Rating Scale in 95% of cases, on 
the Conners ARS in 90% of cases, on the Barkley-Murphy ADHD rating scale in 75% of 
cases, and on the Wender Utah in 65% of cases, after reading DSM-IV criteria.  These 
results, although consistent with literature examining the measures' abilities to separate 
ADHD from other clinical profiles, are alarming.  They highlight how little preparation 
may be necessary in order to provide evidence of ADHD impairment.  In light of this 
"internet age," where vast amounts of information are available to read and "to go" at the  
click of a button, these data are even more concerning. 
Summary and Statement of the Problem 
 There is no question that significant incentives exist for college students to seek 
ADHD diagnoses regardless of whether or not they believe they genuinely have the 
disorder.  The recently-growing base rates of ADHD diagnostic evaluations and treatment 
prescriptions, discussed above, suggest that this is an area requiring attention.  
Unfortunately, it is also apparent that existing diagnostic procedures are weak at 
distinguishing ADHD from other clinical disorders, and very little information is available 
regarding their robustness to feigning.   
Before researchers can make accurate claims about measures' abilities to separate 
ADHD from other clinical conditions, it is necessary to understand how successful such 
tests are at ruling out feigned inattention.  Thus, significantly more evaluations of the 
symptom self-report, computerized impulsivity / inattention measures, objective feigning 
measures, and even standard neuropsychological tests need to be undertaken.  In order to 
generalize results of such research to a college population, it is necessary to conduct such 
work within relevant samples. 
 It is not enough to simply conduct analog evaluations of the various tests with a 
clinical comparison group, however.  In order to develop sound predictions of how well 
results will hold up in the real world, it is necessary to conduct research that is as 
ecologically valid as possible.  Educated individuals intent on receiving a diagnosis of 
ADHD will likely not just arrive for an evaluation unprepared, in hopes of "getting 
lucky."  Minimally, they will probably educate themselves about the disorder.  This can 
be done with very little effort today, thanks to the Internet.  Unfortunately, the ecological  
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 validity of the existing studies described above has been an obvious weakness. 
Goals of the Present Study  
The present study investigates whether various well-validated ADHD-related, 
standard neuropsychological, and symptom validity measures previously studied in other 
populations may be extended to an undergraduate ADHD-diagnostic setting where 
feigning may occur. The measures’ abilities to separate actual and feigned ADHD 
groups, and to accurately classify individuals as clinical or not, will be evaluated.  In 
order to produce the most ecologically valid results, the methodological focus will be on 
adequately motivating and preparing feigners for their role.  Preparation will involve 
providing information obtained directly from the internet to students, and allowing them 
time to process this information and develop a "plan of action."  Motivation will come in 
the form of financial incentive for “successful” feigning.  In order to provide results that 
are practical for clinicians, measures will be selected based upon their popularity and 
economic appeal (for cost and time) in clinical practice, in addition to their previously 
identified psychometric strengths in either ADHD or other neuropsychological domains. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Copyright © Myriam J. Sollman 2008 
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 Chapter Two:  Method 
Participants
 Participants were eighty undergraduates at the University of Kentucky.  Two 
groups were sought:  students without ADHD (“Presumed Normals”) and students with a 
previous, verifiable diagnosis of ADHD.  Presumed Normals were screened to rule out 
any comorbid disorder that presents similarly to attention/concentration difficulty, 
including learning disabilities, diagnosed or self-perceived psychiatric conditions, 
neurological disorders, and a history of head injury.  A diagnostically “clean” ADHD 
group was also sought, and those with comorbid neuropsychological, neurological, and 
psychiatric conditions were excluded.  ADHD referrals were additionally asked what 
types of procedures they underwent for diagnosis (neuropsychological testing, symptom 
self-report, parent interview, classroom observation, teacher rating, et cetera) to 
maximize diagnostic integrity.  Students reportedly diagnosed in a brief office visit or 
using only symptom report were excluded.  
 Both Presumed Normal and ADHD participants were recruited via the University 
of Kentucky Introductory Psychology class Mass Screening Session.  This is a non-
required class period where students interested in fulfilling a research exposure 
requirement by participating in research studies, rather than reviewing journal articles, 
anonymously fill out multiple pre-screening questionnaires.  The questionnaire used in 
this study is provided in Appendix A, and examines the above-mentioned diagnostic 
characteristics.  This questionnaire served to identify both prospective Presumed Normals 
and some ADHD participants.  
 ADHD participants were identified in several ways.  As noted, some were initially 
selected using results from the mass screening.  Additional ADHD participants responded 
to a flier (Appendix B) either posted in the University Disability Office (UDO) or 
emailed to ADHD-diagnosed students registered there.  All ADHD-diagnosed students 
were asked if they were registered with the UDO as having ADHD, or could provide 
proof of their diagnosis at the time of participation, before being selected as a participant.  
Procedure
 Either a senior research assistant (identifying herself by first name and affiliation), 
or the primary investigator contacted eligible Presumed Normals identified from the 
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 subject pool to screen them further (Appendices C-D).  Those who continued to meet the 
previously described criteria were scheduled for participation.  The primary investigator 
of this study contacted all eligible ADHD participants for full screening, in order to 
maximize confidentiality.  ADHD participants were told that they would be contacted at a 
later date if they met inclusion criteria, which additionally included willingness to skip 
their medication for a twelve-hour wash-out period prior to testing.  This was done so as 
not to give away inclusion criteria.  Those qualifying were subsequently phoned by the 
same individual, told of the medication requirement, and asked again if they would like to 
participate.  Scheduling was arranged to be at the safest and most convenient time for that 
student, in light of this.  Subjects were called twenty-four hours before participation with 
a reminder of the appointment and medication requirement.  Because of this 
methodology, and reimbursement requirements, the primary investigator was not blind to 
participants’ clinical status.   
 As compensation and incentive for participation, Presumed Normals were told 
they would receive two research credits (of their required six) at testing completion.  (In 
reality, some participants received greater incentive, as described later).  ADHD 
participants were offered a choice of two research credits and $15 (for medication-related 
inconveniences), or $45 and no research credits.  So, ADHD participants not enrolled in 
Introductory Psychology always got $45, as research credits were not useful for them. 
 Presumed Normal participants were tested using two examiners, where one  
(RA1) provided pretesting and preparation protocol, and another, blind examiner 
completed the testing battery (RA2).  RA1 obtained informed consent and administered a 
demographic and diagnostic questionnaire (Appendix E) as well as a “word reading test” 
for IQ estimation (Wechsler Test of Adult Reading [WTAR; Wechsler, 2001]).  RA1 
then provided information about the study and the procedures to come.  To maintain 
confidentiality and give students a chance to recall any diagnoses they neglected to tell 
the phone screener, the demographic questionnaire was completed in privacy and sealed 
in an envelope by the evaluee.   
 After being informed about the nature of this study, Presumed Normal students 
were randomly assigned to an Honest (HON) or Feigning (FGN) condition by selecting 
from two envelopes with enclosed role-specific information.  RA1 instructed participants  
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 not to disclose their role to RA2, who would be testing them.   
Students in the HON condition received an explanation of the purpose and 
importance of a normal control group, and were asked to take the tests to the best of their 
ability.  They were then asked to remain in the testing room for a few minutes, until RA2 
was ready.  FGN-condition students were congratulated with excitement in order to 
increase their attention, involvement and motivation; they were then  told that if they 
were “successful” in that assignment, they would receive $45 in addition to the two 
research credits already offered.  They were then provided with a feigning scenario (see 
below), followed by information about ADHD.  This information was obtained from the 
first few listed Google “hits” for ADHD and ADHD diagnosis (Appendix F) at the time 
of study inception, Fall 2006.   FGN-role individuals were then given instruction to take 
five minutes to read through the scenario and internet information (presented in a pseudo 
web-page format), and to take notes.  Prior to reading, they were encouraged to think 
about how this information would relate to their presentation in a testing evaluation. 
 
Feigning Scenario:  
Your roommate has been diagnosed with ADHD.  S/he had trouble with classes, but 
then was given some medication for ADHD, and now does well.  S/he even got a 
couple of A's recently, and has more time to socialize because studying is not as 
hard!  During your midterms, you decided to try your roommate's medication, and 
ended up surprising yourself with how much easier things went.  You may think that 
you have undiagnosed ADHD, so you "Google" the disorder to learn more about it.  
On the following pages are some of the things that you find.   
 
When you are done reviewing these materials, please use the colored paper to jot 
down symptoms that will help you remember how to fake on the tests you will be 
given. Tell the examiner when you are done. 
 
After their five-minute preparation, FGN students were asked to describe symptoms 
of ADHD and to share how this disorder may affect testing results.  They were then told 
to remember that they are “presenting” as a university student, so must do at least as well 
as someone who would be admitted to the University of Kentucky.  They were cautioned 
not to reveal their role or to feign too blatantly lest they lose the $45 incentive.  (In 
reality, however, all FGN students received the $45 incentive due to Internal Review 
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 Board guidelines.)   Students who appeared inadequately prepared were asked leading 
questions about symptoms, such as, “How would someone with ADHD pay attention to a 
lecture?”  They were not ‘coached to the tests’ through information that symptom validity 
measures were imbedded or through instruction about what symptoms to fake on certain 
types of tasks.  FGN-role participants were then given the post-preparation instructions  
below, by RA1, reminding them of cautions and incentives.  
 
Post-Preparation Instructions: 
You will now be introduced to the person who will complete testing with you.   
Please take the following tests as if you are trying to convince someone that you 
have ADHD.  It is not necessary for you to try to act  like you have ADHD; you 
only need to respond to the test items as if you do.  The examiner who tests you will 
not know your role, so please do not give it away!   
 
Remember, if you are successful at deceiving the tests and following instructions 
throughout, you can win $45! 
 
If you have any questions, please take time to ask me right now. 
 
 Students in the ADHD condition (ADHD) were all tested by the primary 
investigator.  All participants were debriefed (Appendix G) and provided a manipulation  
check (Appendix H) to determine if they understood what they were asked to do and 
complied with their instructions.  Students were then compensated for their participation.   
Materials
Pretesting Measures
Pretesting measures included the demographic questionnaire (Appendix E) and 
the WTAR (described below). 
 Wechsler Test of Adult Reading (WTAR; Wechsler, 2001)   
The WTAR is a word-reading test for individuals aged 16-89 that utilizes 
atypically-pronounced (i.e., nonphonetic) words.  It is used to estimate intelligence level, 
or premorbid intelligence level when damage-related declined is suspected, because 
reading recognition is relatively stable in the presence of brain insult (though not immune 
to effects of notable intellectual impairment [see Spreen & Strauss, 1998; Putnam, 
Ricker, Ross, & Kurtz, 1999 for reviews, as provided in test manual]).  For this purpose, 
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 it was selected for inclusion in order to evaluate HON, FGN, and ADHD groups’ 
intellectual equivalence. 
The WTAR's US Standardization sample was a nationally-representative, 
stratified sample of 1,134 adolescents and adults aged 16-89.  Target values for 
stratification closely matched 1995 US Census data for age, gender, race/ethnicity, 
education, and geographic region.  However, standard normative data are provided by 
gender, age (16-17, 18-19, 20-24, 25-29, etc.), and ethnicity.   
The WTAR displayed excellent internal consistency (alpha = .90 to .92 for ages 
18—34).  Standard errors of measurement were relatively adequate (+ 8.1 to 9.5 points at 
95% Confidence Interval for ages 16—34), and excellent test-retest reliability for a mean 
inter-test interval of 35 days (corrected r = .92 for adults aged 18—29).  It also 
demonstrated very good convergence with the AMNART, as evidenced by a mean 
correlation of .90.  Moderate correlations between the WTAR and the WAIS-III Verbal 
IQ were demonstrated by the standardization sample, ranging from .74 (age 18-19) to .79 
(age 20-24) for college-aged adults.  Similar correlations were found with the Full Scale 
IQ (.70 for age 18-19 and .74 for age 20-24), though the WTAR tends to predict the VIQ 
slightly better than the FSIQ in all age groups.  Thus, the WTAR appears to be a fairly 
good source of Verbal IQ estimation.   Further, data presented in the manual suggest it is 
a good indicator of IQ for ADHD evaluees as well. 
Materials for Remainder of Protocol
Tests administered by RA2 after the pretest and preparation period included 
ADHD-related measures, symptom validity tests, and neuropsychological measures.  
These were given in a counter-balanced fashion, with one of the symptom validity tests 
always administered first.    
ADHD-Related Measures.  Two ADHD symptom report measures (the Murphy & 
Barkley ADHD Rating Scale [ARS], Current Symptoms and Childhood Symptoms 
subscales; the Conners’ Adult ADHD Rating Scale—Self Report, Long Version 
[CAARS—S:L]), and a computerized continuous performance task (the Conners’ 
Continuous Performance Test [CPT]) were administered.  The ADHD group participants 
were asked to complete the symptom-report measures with regard to how they currently  
felt when unmedicated, so that results would provide their clinical profile. 
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 ADHD Rating Scale (ARS): Current & Childhood Symptom Checklists (ARS) 
These indices, first published by Kevin Murphy and Russell Barkley in 1996, are  
commonly used in the assessment of ADHD for individuals over the age of 12.  The ARS 
Current and Childhood Symptoms scales were constructed using the 18-item DSM-IV 
symptom list.  Evaluees are asked to rate the extent to which they have been experiencing 
various symptoms within the past 6 months (Current Symptoms Checklist), and from age 
5-12 (Childhood Symptoms Checklist), using a Likert scale that ranges from 0 ("Never or 
rarely") to 3 ("Very often").  Nine Inattention items are alternated with nine Hyperactivity 
items on each index.  The forms are hand scored, and each completed index produces 
three "Symptom Count" scores on both the Childhood and Current Symptoms indices.  
The Inattentive and Hyperactive symptom counts are the sum of their relevant items rated 
"2" or "3."  A Total ADHD Scale for Childhood and Hyperactive symptoms is the 
summation of the two counts.  Murphy and Barkley (1996) provide norms for the 
population of interest; these are also recommended in Barkley, Murphy, & Fisher (2008).  
The authors recommend that both Current and Childhood criteria are met to fulfill DSM-
IV criteria.  In the developmental sample, consisting of individuals applying for or 
renewing Massachusetts driver's licenses, no gender effects were demonstrated for  
Current symptoms. Childhood ratings produced greater symptom endorsements by males. 
 As discussed in the introduction, susceptibility of the ARS to feigning has been 
investigated in three studies, only one of which was a simulation design, however (see 
Tables 1-1 and 1-2).  In Quinn’s (2003) simulation study, and Jachimowicz & 
Geiselman’s (2004) and Fisher’s (2007) quasi-experimental evaluations, the measure was 
successfully faked.  Quinn (2003) reported small effect sizes (g)  for both Current (M = 
0.4) and Childhood (M = 0.0) symptoms in comparing feigned and ADHD student 
profiles; Jachimowicz and Geiselman (2004) stated that ADHD profiles were obtained by 
75% of feigners; and Fisher (2007) reported successful faking by 77% of undergraduate 
feigners.  Though these rates seem alarming, the latter two studies provided evidence that 
the ARS was significantly less susceptible to feigning than other tests examined, which 
were falsified by up to 95% of feigners. 
 Thus, the ARS was selected for inclusion for its potentially greater resilience, as 
well as due to its common use and economics—usage is free and unlimited to examiners 
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 who purchase the book.  As with the CAARS—S:L (described below), the ARS was 
derived directly from DSM-IV diagnostic criteria.  Thus, it has the potential to have 
either strong convergence, or redundancy (a weakness), with the CAARS—S:L.  
However, the ARS adds information about childhood symptoms, which is required by the 
DSM-IV for diagnosis.  Moreover, because symptom scales are indicated only for the 
support of diagnostic decisions, and because two current symptom indices are not likely 
given within the same evaluation, the impact of such redundancy is limited.   
Conners’ Adult ADHD Rating Scale, Self-Rating Form, Long (CAARS-S:L)   
This measure (Conners, Erhardt, & Sparrow, 1999) is commonly used in the 
assessment of ADHD with individuals 18 and older.  The CAARS—S:L has adult 
evaluees rate the extent to which they have "recently" been experiencing various 
symptoms of ADHD on a 4-point Likert scale ranging from 0 ("Not at all, Never") to 3 
("Very much, very frequently").  Responses are hand-scored on the carbon-write form as 
indicated by specific instructions, and presented as age and gender-stratified T-scores 
arranged on 8 subscales and an Inconsistency Index.  T-scores greater than 65 correspond 
to a "clinical elevation."   
The eight subscales of the CAARS—S:L include four DSM-IV-derived 
"diagnostic" indices, four factor-derived subscales, and an Inconsistency Index.  The 
latter index, generally examined first, estimates whether the pattern of responses is 
consistent across items, and is calculated by finding the sum of absolute differences 
between eight highly correlated item pairs.  Cutoff scores indicative of inconsistency 
were derived by comparing profiles of 100 respondents from 100 computer-generated 
(random) profiles, which resulted in 96% sensitivity and 96% specificity.  This Index 
increases the clinical appeal of the CAARS—S:L. 
 After examining the Inconsistency Index, clinicians are urged to consider the 
diagnostic indices, with T-scores above 65 being clinically significant.  The diagnostic 
indices first include the ADHD Index (“Scale 8”), which is a summary score reflecting 
whether the evaluee has clinically significant levels of ADHD symptoms compared to 
other adults.  Scale 8 is said to differentiate clinical from non-clinical levels of ADHD 
symptomatology, and to be the best screen for identifying "at risk" individuals (see test 
manual).  Next, the DSM-IV Inattentive Symptoms subscale (“Scale 5”)  provides an 
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 indication of whether the rater has clinically significant levels of inattention, 
corresponding to the current diagnostic criteria.  It contains nine items and is based 
directly upon the nine inattentive symptoms provided in the Diagnostic manual.  The 
DSM-IV Hyperactive-Impulsive subscale (“Scale 6”) provides the same information for 
the alternative diagnostic subtype, also including nine items corresponding directly to 
those in the DSM-IV.  Finally, the DSM-IV Total ADHD Symptoms subscale (“Scale 7”) 
indicates whether the individual meets criteria for ADHD according to the DSM-IV; it is 
based upon the sum of the two preceding subscales.    
 After considering the diagnostic indices, the clinician may turn to the factor-
derived subscales for more information regarding the evaluee's specific areas of 
difficulty.  These include the Inattention/Memory Problems scale (with high scores 
corresponding to slower learning, organizational difficulty, and trouble completing tasks 
and concentrating), the Hyperactivity/ Restlessness scale (with high scores reflecting 
difficulty working on one task for prolonged periods as well as greater feelings of 
restlessness than others), the Impulsivity/Emotional Liability (reflecting impulsive 
behavior, sudden mood changes, and quicker anger and irritation than others), and lastly 
the Problems with Self-Concept (which reflects poor social relationships, low self-
esteem, and low self-confidence).   
 Although the diagnostic subscales are generally examined first, CAARS—S:L 
scores are generally interpreted in light of the number of clinically-elevated subscales (at 
T > 65).  If only one elevation is present, the pattern of symptoms is said to be 
"marginal."    
The CAARS—S:L was developed from an original item pool of 93 statements, 
administered to 839 nonclinical adults.  Factor analysis revealed 66 items on four factors, 
accounting for 46.8% of the total variance.  The normative sample consisted of 1,026 
adults.  A satisfactory mean inter-item correlation was demonstrated for each scale 
(excluding the Inconsistency Index).  Moderately high mean test-retest reliability was 
found (.91), suggesting that the measure is only mildly susceptible to temporal 
variability.  Good validity characteristics were also demonstrated.  As with the ARS, the 
CAARS:S—L does not appear to have been cross-validated with other ADHD current 
symptom scales.  An evaluation of its convergence with the Wender Utah Rating Scale, 
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 an assessment of childhood symptoms, demonstrated only moderate correlations (.37—
.67; see Macey, 2003).  Discriminant validity was demonstrated using DSM-IV 
diagnosed adults (Erhardt et al., 1999).  The ADHD Index in particular demonstrated a 
sensitivity of .71 and a specificity of .75 in a cross-validation involving 192 adults.   
 Susceptibility of the CAARS to falsification has only been evaluated by 
Jachimowicz and Geiselman (2004), as described above, where 90% of college students 
asked to read DSM-IV criteria were able to create ADHD-like profiles.  Additional 
weaknesses of this index include marginal correlations between Self and Observer (Long) 
ratings for both males and females (Range = .42 to .61 for men, .45 to .61 for women), 
administration length, and the absence of a childhood symptom evaluation, as stated 
above.  The measure's psychometrics for use with ethnic or racial minority evaluees have 
been poorly examined, and the test manual does not provide the normative composition 
of such groups (Macey, 2003). 
 Despite flaws, the CAARS—S:L was selected for inclusion in this study for 
several reasons beyond the appeal of its Inconsistency Index.  The CAARS was 
developed by one of the foremost researchers of ADHD, and been relatively well-
validated.  Self-report measures of ADHD symptomatology should be of great interest in 
ADHD feigning research, as they are very commonly used in ADHD diagnostic 
evaluations.  Such measures provide a great deal of information while requiring very little 
clinician time.  Research shows that many health care providers, particularly primary care 
providers, use these to arrive at a diagnosis (Eliott, 2002, as cited in McCann & Roy-
Byrne, 2004).  For these reasons, obtaining an indication of the measure's vulnerability to 
exaggerated or feigned responses should be of great interest.   
Conners' Continuous Performance Test (CPT)—II for Windows   
The Conners' CPT (C-CPT hereafter; Conners, 2000) is one of several 
computerized tests commonly used to screen for problems that may be associated with 
ADHD, including impulsivity and inattention.  It measures sustained visual attention, 
response inhibition, and response rate.   
In the C-CPT, evaluees are asked to hit the spacebar every time they see a letter 
other than "X" on the screen.  Letters are flashed in one location, one at a time at variable 
intervals for 15 minutes.  The C-CPT is scored in terms of errors of omission (missing 
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 targets) and commission (responding to non-targets), hit reaction time, hit reaction time 
standard error, and variability of  standard error, among other factors.  Failure to respond 
to target stimuli is considered an indication of inattention, while responding to non-target 
stimuli is considered a reflection of impulsivity or motoric disinhibition.  Both are 
traditional indicators of ADHD, although the extent to which they are manifested is 
thought to vary with diagnostic subtype (Homack & Reynolds, 2006).   With regard to 
the utility of hit reaction time, evidence has been conflicting.  The construct has typically 
been labeled an indication of "processing efficiency."  However, several factors, 
including motivation,  may effect response time, and more recent literature has suggested 
that ADHD evaluees have "normal" reaction times, on average (see Hervey, Epstein, and 
Curry, 2004).  Instead, the standard error for response time may be considered as an 
indication of the variability of "attentiveness."   
CPTs are generally similar in that evaluees are asked to respond to some stimuli  
while ignoring others for a prolonged period of time, with variable target presentation 
frequency.  Conners' version differs from others in that it has a large number of target 
stimuli embedded in a small number of non-target stimuli, rather than the reverse.  Thus, 
it should theoretically tap disinhibition for non-target stimuli (i.e., commission errors) 
better than the other measures. Literature has shown that the measures with a low number 
of target stimuli discriminate omission errors better than the C-CPT (see a meta-analytic 
review by Hervey et al., 2004).  In addition to omission and commission error scores, the 
C-CPT provides a hit reaction time, standard error, and a standard error variability score.  
A T- score of 60 or greater on any C-CPT index is said to be a high probability marker of 
attentional problems (Conners, 2000).   
Conners' CPT was developed and normed using more than 2000 individuals.  Of 
those aged 18-34, however, only 237 were non-clinical and only 48 had a diagnosis of 
ADHD.  No age effects were found in the adult samples.  Adult gender effects may be 
observed for commission errors.  Overall, a high split-half reliability was found for hit 
reaction time (.95), omissions (.94), standard error (.87), and commissions (.83), with 
variability (.66) lagging.  Moderate test-retest reliability was noted across these indices, 
ranging from .84 for omissions to .60 for variability.  Results of validity assessments 
suggest that the above indices generally discriminated the clinical (ADHD and 
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 neurological) and non-clinical adult normative groups, despite the relatively small sample 
sizes.  Likewise, a multi-site study of 107 ADHD cases, 223 neurologically impaired, and 
437 non-clinical cases provided in the manual resulted in a high sensitivity for ADHD 
(88%) and neurological patients (85%); with a moderate specificity for non-ADHD 
(87%) and non-neurological (92%) patients.   Looking specifically at the ADHD versus 
normal control normative data, ADHD individuals performed statistically significantly 
worse on all indicators.  However, these data were derived from "pure" contrasts of 
ADHD patients vs. normals, or neurological patients vs. the same normals, so the 
diagnostic accuracy of an ADHD vs. neurological group is unknown.   Also, this finding 
is challenged by another study suggesting that the C-CPT was unable to discriminate 
ADHD and normal control adolescents (Homack & Riccio, 2005).    
Although the above data are somewhat encouraging, further evaluation is needed, 
particularly with mixed clinical groups.  Other studies have demonstrated that the C-CPT 
is insensitive to differences between ADHD and PTSD (Schmitt, 2000) in addition to 
other anxiety disorders, depression, and Cluster A personality traits (see Homack & 
Reynolds, 2006).  An evaluation of the measure's convergence with ADHD rating scales 
in adults diagnosed only with ADHD demonstrated a lack of correlation between results, 
though restriction of range may have been an issue (Epstein, Conners, Sitarenios, & 
Erhardt, 1998).   Performance has also been shown to be affected by anxiety (see test 
manual; Schweiger et al., 2007).  The general consensus is that CPTs only provide 
information about the presence of symptoms of disorders involving attention problems 
and impulsivity, rather than information about the presence of a specific disorder 
(Homack & Reynolds, 2006).  Not surprisingly then, the C-CPT is indicated only for use 
as a screen for the presence of attention-related problems.   
 Despite weaknesses and limitations, the C-CPT was chosen for inclusion in this 
study because its susceptibility to feigned dysfunction requires further evaluation.  
Booksh (2005) demonstrated a lack of separation between simulated and diagnosed 
ADHD groups on C-CPT indices, using a college sample (g range = 0 to 0.7).  However, 
the same study also obtained high g’s of 1.4 (for Hit Rate Variability of Standard Error) 
and 1.1 (for Commission Errors) in the separation of normal honest and ADHD-
diagnosed students, as well as a high g of 1.1 (for Commission Errors) in the separation 
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 of the normal honest and feigning groups, pointing to its potential.  These results contrast 
with an undergraduate simulation study of the IVA-CPT (which includes auditory and 
visual stimuli); this study found that the IVA was "not fakable" on more than 80% of its 
scales (Quinn, 2003). Across three different impairment indices, a mean sensitivity to 
feigning of .85 and a mean specificity of .85 were found.  Looking specifically at the full 
scale indices using the Response Control and Attention Quotient published cutoffs, 
sensitivity was .81 and specificity was .91.  This contrast from C-CPT results provides 
interest in replicating the Booksh evaluation.     
 Standard Neuropsychological Measures 
 Several neuropsychological tests were included to increase the ecological and face 
validity of the test protocol as a neuropsychological battery.  Unlike the symptoms 
reports and C-CPT, these measures do not assess ADHD in such a transparent way.  Also, 
they detract attention from the malingering tests described below.   
Stroop Color-Word Test  
Several version of the Stroop measure exist, but the variant selected for this  
study, the Charles Golden version (Golden, 1978; Golden & Freshwater, 1999) was one 
commonly used in neuropsychological practices.   In this version, evaluees first read 
aloud a list of color names as quickly as possible, for 45 seconds ("Word" subtest). Then, 
the ink color that "XXXX" is printed in is stated for 45 seconds ("Color" subtest).  Lastly, 
the ink color used to print various incongruous color names is named for 45 seconds 
("Color-Word" subtest).  In each trial, errors are identified and the evaluee must correct 
them before going on.  The total number of correct items and the total number of errors 
are indicated in the score of each trial.  The test manual recommends that subtest raw 
scores first be converted to an age and education-corrected T-score using equations 
provided in the manual.  These corrections were derived from the prediction of "normal" 
performance using an updated normative sample.  Following calculation of T-scores, the 
"Interference Score" is calculated using the raw Color and Word scores.  This score is 
said to represent the ability of an individual to inhibit word naming when reading ink 
color in the Color-Word subtest, and was originally based upon the amount of time to 
read one Word item followed by one Color item (45/total Word + 45/total Color), which 
would translate to CW= (W*C) / (W + C) when considering the number of items that 
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 should be completed on the Color-Word subtest.  Although all scores are corrected for 
age and education only, several studies have demonstrated gender effects for reading the 
Color page, although not the Color-Word page in college students (Jensen, 1965; Stroop, 
1935; Brown, 1915), as well as younger individuals.  This needs to be considered when 
examining results of the present study.  Additional considerations are provided below.   
 Hervey, Epstein, and Curry (2004) conducted a meta-analytic review of 33 
published studies contrasting performance of ADHD and "normal" adults on various 
neuropsychological measures.  Seven studies evaluated the Color-Word difference score 
in the Golden version, and found a mean g of .47, suggesting that this index is moderately 
effective at discriminating ADHD and non-ADHD adults.   For the Golden-derived 
interference score, however, the g was just .19, suggesting that this does not effectively 
discriminate these groups.  The review had several major limitations, though, most 
notably uncertain criterion status due to inconsistent diagnostic criteria and assessment 
procedures.  Several authors have suggested that the difference score and Golden method 
of quantifying interference are ineffective for various reasons (see Chafetz and Matthews, 
2004; Lansberger, Kenemans, & van Engeland, 2007 also provide a review of this issue).   
In turn, Lansberger et al. (2007) conducted a meta-analytic review of 19 studies 
employing any Stroop color-word version in a comparison of DSM-IV-diagnosed ADHD 
individuals and "normal" controls.  These authors employed a ratio score of Color to 
Color Word time per item, and found that interference control was consistently 
compromised in ADHD individuals regardless of age.  The mean effect size for tests 
scored in time-per-item was g = 1.11.  Using the items in 45" scoring, however, there was 
great variability between studies.  Unfortunately, the resulting effect size was not 
presented.  In addition to these results, the authors demonstrated that ADHD individuals 
were consistently slower in base word reading (for 13 studies that provided these data, 
t(12) = 5.19, p < .001).  Thus, when scoring and analyzing data from the present study, it 
may be appropriate to examine the base word reading T-score as well as the time per 
item.  The Stroop task was selected for inclusion in the present study for its utility in 
ADHD evaluations, as well as to increase the ecological validity of the battery as that of a 
diagnostic evaluation.  
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 Nelson-Denny Word Reading Test: Reading Speed Component    
In this measure, a short non-fiction work is provided to participants, and they are  
instructed to read it at their normal reading rate so that they may comprehend and 
"absorb" the material, as "questions may be asked after."  Individuals are instructed to 
mark where they were after one minute of reading, by circling the corresponding number 
at the right-hand side of the line they were on when told to stop reading in the present 
study.  No questions were asked; only the reading speed score was used.   
 The Reading Speed Component of the Nelson-Denny Reading Comprehension  
Test (“N-D Comp”) was chosen for inclusion in the present study as some literature has 
suggested that ADHD individuals perform significantly worse than their non-ADHD 
peers (see Brock, 1996; Seidman, Biederman, Faraone, & Milberger, 1995).  Moreover, 
laypeople often associate slow reading with attentional problems.  The research on this is 
mixed, however, with greater evidence implicating reduced comprehension than 
inattention per se (Brock & Knapp, 1996; Cordon, Kahl, & Wahl, 2006).  This,  however, 
cannot be assessed in a timed test without evaluation of reading comprehension.  In the 
very least, this measure will serve to increase the ecological validity of the assessment 
and to deter students from developing suspicion about the nature of the measures 
administered, and may provide a gross indication of the difference between simulated and 
diagnosed ADHD reading speed performance. 
Wechsler Memory Scale—Third Edition, Word Lists Subtest 
Word Lists (“WMS-III WL”) is an optional subtest from the WMS-III.  It 
involves memorization of 12 common, but neither semantically nor phonemically related 
words (List A).  This distinguishes it from other full reminding procedures, such as the 
California Verbal Learning Test (CVLT; Delis, Kramer, Kaplan, & Ober, 1987), which 
provide words that can be grouped into several semantic categories.  In the WMS-III WL, 
the examiner reads this list four times, each time after which the evaluee freely recalls all 
words remembered in any order.  Then, without instructing individuals to remember the 
original list, a second 12-item list is provided for memorization and free recall one time 
(List B).  Finally, incidental memory of the first list is assessed with free-recall of those 
items (Short-Delay Free Recall).  Intrusions are recorded, and for this study, repetitions 
were also recorded.  A long-delay recall and recognition trial are also available, but these  
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 were not included in the present study. 
Five raw scores are calculated from evaluee responses.  The "First Recall Total 
Score" is the sum of items recalled in List A Trial 1 and List B.  The "Recall Total Score" 
is the sum of all items recalled from List A and List B.  The "Learning Slope" describes 
rate of acquisition and is the mean number of items added per trials 2-4.  "Contrast 1" 
score describes the difference between the number of items recalled on Trial 1 List A and 
List B.  Lastly, the "Contrast 2" score describes the difference between number of items 
recalled in Trials 4 and Trial 1.  Each of these raw scores is converted to a T-score based  
upon age group (18-19 or 20-24, 25-29, etc.).   
The WMS-III standardization sample consisted of a demographically 
representative group of 1,250 individuals aged 16-89.  Reliability and validity data are 
not presented for the WL itself as it is a supplemental subtest not scored on any scale, but 
internal consistency is said to be greater than .70 for all subtests (see test manual).  Test-
retest reliability for adults up to age 54 after a one-month period was found to be .61, 
suggesting that performance on this subscale is susceptible to some temporal variability. 
Notably, several feigning indices were developed or adapted for the WL scale in a 
2005 dissertation (Larson, 2005).  However, only one of these does not involve the long-
term delayed recall portion of the WL.  Responses from the immediate-recall trials listed 
above can be used to calculate a Recall Consistency Index.  This index was based upon 
the Recall Consistency Index (Demakis, 1999) created for the CVLT.  Larson's Recall 
Consistency Index is a measure of consistency across only the learning trials of List A.  
Each time a correct word is recalled in two successive trials, it is counted.  (As such, each 
word could potentially be counted three times).  The score is the sum of these counts 
divided by the total number of words recalled in Trials 1—3.  Score interpretations are 
found in Appendix I of the WMS-III manual. 
Larson (2005) evaluated this index using a within-subjects simulation design that 
included a clinical control group.  Twenty community volunteers and twenty non-
litigating TBI patients with no current or past psychiatric diagnoses were asked to 
complete measures to the best of their ability, and then, following a 10-minute break, to 
simulate memory impairment.  An effect size of d = 1.35 was found for the community 
volunteer group, suggesting that it was a very good discriminator in a presumably 
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 unimpaired group; for the TBI group, the index was a mere d = .23.  This suggests that 
the index may only be useful for individuals without memory impairment.  However, 
classification accuracy was not calculated in that study, and these results do not preclude 
the possibility that  high true positive and true negative rates may be obtained using the 
Inconsistency Index with non-impaired individuals, such as college students. 
The WMS-III WL was included as a measure of immediate memory, and to 
investigate the utility of the Inconsistency Index for feigned cognitive impairment.  
Additionally, as with the other "true" neuropsychological measures, it served the purpose 
of preventing participants from realizing that multiple feigning detection tools were being 
administered.  Other questions may be addressed through inclusion of this measure.  For 
example, at this time, very little research exists on list learning abilities of ADHD-
diagnosed young adults.  Intuitively, distractibility may be associated with poorer initial 
list acquisition.  A narrative review of neuropsychological testing results in ADHD 
versus normal controls conducted by Woods, Lovejoy, and Ball (2002) demonstrated a 
trend towards poorer performance on measures such as the California Verbal Learning 
Test.  However, examination of list learning in younger students has shown that they can 
perform in the Average range (see Mahone, Koth, Cutting, Singer, and Denckla, 2001).  
Additionally, no comparisons of feigning and ADHD college students exist for List 
Learning Tasks.   
It was hoped that performance patterns might be assessed in order to understand 
both differences between honest and feigning ADHD "evaluees" and the performance of 
individuals diagnosed with the disorder.  Errors of commission and repetitions, which 
may reflect impulsivity; or errors of omission, which may reflect distractibility (among 
other neuropsychological functions) may be noted from the ADHD group.  Mahone et al. 
(2001) found a greater number of intrusion errors by ADHD-participants than by normal 
controls.  Of course, performance of children may not generalize to adults. 
Neurocognitive Feigning Measures  
 36-Item Short Form, Hiscock-Hiscock Digit Memory Test Card Version 
The Digit Memory Test (DMT) is considered by many to be the "gold standard" 
of neurocognitive feigning tools (Vagnini et al., 2006; Vickery, Berry, Inman, Harris, & 
Orey; 2001). This measure involves presenting a 5-digit stimulus, then a delay, and then a 
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 two-alternative forced-choice recognition trial.  The first "block" of items has a 2.5-
second delay; this is increased to 5 and then 10 seconds in attempt to make the test appear 
as if it is becoming more difficult.  Two score thresholds are useful in evaluating results 
of the DMT:  less than 90% correct, and statistically significantly below chance.  The 
former was derived from normative studies of non-compensation seeking individuals 
with neurological damage instructed to perform to the best of their ability, and thus 
represents the point at which probable feigning may be suspected.  It was derived by 
maximizing specificity.  The latter is said to detect deliberate attempts to feign, derived 
from the binomial theory.   
Two meta-analytic reviews of primarily neurological patient groups have 
demonstrated the procedure (Vickery et al., 2001) and a computerized variation (Sollman 
& Berry, Under Review)—the Victoria Symptom Validity Test (Slick, 1999)—to have 
the strongest sensitivity of all measures reviewed, as well as very high specificity.  In 
addition, very large effect sizes in the separation of purportedly honest and feigning 
individuals has been demonstrated in the same reviews for those test variations (d = 1.95,  
g = 2.71, respectively).  The DMT was selected for this study due to these characteristics.  
Letter Memory Test (Card Version)  
The Letter Memory Test (LMT; Inman et al., 1996) was developed as an 
alternative to the DMT under the assumption that increased public knowledge over time 
may reduce utility of a measure.  As with the DMT, the LMT was created to increase 
evaluees' belief that it assesses memory and becomes more difficult over time.  However, 
it manipulates the number of characters (letters) presented, as well as the number of 
alternative choices in the recall trial, rather than the delay length.  For this measure, the 
specificity-maximizing cutting score for probable feigning is 93%. 
 A meta-analytic review of known-groups and clinically-enhanced simulation 
design studies is presented in Sollman & Berry (Under Review).  This study provides 
evidence that the LMT has a strong ability to separate groups of known or probable 
feigning and honest individuals (g = 1.79).  Although this effect size is significantly 
lower than that of the DMT’s computerized counterpart, it still exceeds Cohen's 
recommendations for a large effect size, when translated into Cohen's d.  In the same 
review, the LMT demonstrated mean sensitivity (76%) and specificity (98%) values that  
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 were statistically equivalent to those of the computerized DMT variant.   
Test of Memory Malingering  
The Test of Memory Malingering (TOMM; Tombaugh, 1996) is another two-
alternative forced-choice measure, but it uses line-drawn "pictures of common objects" 
rather than alpha-numeric characters as with the first two measures reviewed.  Fifty such 
pictures are presented in two learning trials, each of which is followed by a 50-item 
forced-choice recognition trial.  After a 20-minute delay, a final two-alternative 
recognition trial is administered.  The TOMM uses the below-chance criterion described 
above as well as a standard cutoff of less than 90% correct on either Trial 2 or the 
Retention Trial.  In the Sollman and Berry meta-analytic review above, the TOMM was 
demonstrated to have a high g (Trial 2 g = 1.31; Retention g = 1.47), which was not 
statistically significantly different from that of the LMT.  The Trial 2 effect size was 
included in a cross-test comparison and was found to be equivalent to that of the LMT, 
although significantly lower than the computerized DMT variant.  As with the LMT, 
near-perfect to perfect specificities were demonstrated (Trial 2 = 98%, Retention = 
100%).  Sensitivities were statistically equivalent to those of the LMT and computerized 
DMT variant (Trial 2 = 65%, Retention = 68%), although this may be due to the small 
number of contributing studies and the large variation between; a considerable difference 
exists between the sensitivity values of the TOMM and VSVT (81%).   
 Green's Nonverbal-Medical Symptom Validity Test   
This measure (NV-MSVT; Green, 2004) is the computerized "non-verbal" 
component of Green's Medical Symptom Validity Test, which is a shortened adaptation 
of Green's Word Memory Test.  It is said to be usable in any sample regardless of 
language spoken or reading level, though empirical data were not available.  The NV-
MSVT was designed to detect when individuals are providing sub-optimal effort on a 
perceived test of visual memory.  Evaluees are presented with a list of 10 pictures, each 
containing a pair of items, and are asked to name the components of each picture out 
loud. The list is presented twice. Then they are shown two single-component pictures 
side-by-side, asked to name each out loud, and then select the one that was in the ten-
picture list (IR subscale).  Feedback regarding accuracy is given by the computer.  A ten-
minute delay then occurs, and the evaluee is not informed that long-term retention will be 
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 assessed later.  During this delay, the evaluee is asked to memorize a set of 20 pictures 
presented on a two-sided sheet, in one minute.  The test manual instructs the examiner to 
fill the remaining nine minutes with tasks not involving visual memory.  Finally, evaluees 
are presented with two pictures side-by-side and asked to select the one they saw on the 
computer previously.  This delayed recognition portion actually consists of three 
intermixed subscales: the DR, where a new foil is paired with a learned target; the DRA, 
where the two items presented include an easy-to-remember foil from IR with a 
distinctively new foil; and the DRV, where an original target is presented with a similar, 
slightly altered target.  The examiner is asked to leave during this portion of the test, as 
those evaluees intent on exaggerating impairment may be more likely to deliberately 
select the incorrect response when left alone.  Again, the computer provides feedback 
regarding response accuracy.  Next, individuals are provided with a single-component 
picture from the original list of 10 two-component pictures.  They are asked to verbally 
indicate what the missing component is, and the examiner clicks either a green check 
mark (to indicate correct response) or a red "X" (to indicate incorrect response) (PA 
subscale).  Lastly, the computer screen is turned away from the evaluee, who is asked to 
freely recall the items presented in the original list of 10 pictures (FR subscale).  The 
evaluee may recall items singly or in pairs.  At the close of the test, the evaluee is asked, 
"Did you try your hardest on this test?" and their response is recorded on the computer.  
In sum, this measure includes two two-alternative forced choice subtests, and two free-
recall tests. 
 Feigning determination is made according to either of two algorithms.  If the 
mean of all subtest scores falls at or below 90%, or if the mean of DR, CNS, DRA, and 
DRV falls below 88%, the individual is said to be feigning.  The latter is said to be the 
best combination for predicting TOMM or WMT failure according to ROC analysis.  A 
sensitivity of .70 and a specificity of .95 were found for predicting WMT failure at that 
measure's cutting score of <88%.  The cutting scores used for the NV-MSVT appear to 
have been derived from the normal simulation comparison, based upon a graphic 
illustration provided by the author, of these groups’ mean (non-overlapping) scores. 
 To date, there is no test manual and little data on the psychometrics of the NV- 
MSVT. However, the author of this measure provided some data by personal  
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 communication.  First, results of an unpublished non-clinically enhanced simulation 
study illustrate that individuals asked to feign early dementia (N = 39) obtain 
significantly lower scores on all subscales than normal controls (N = 36), with g effect 
sizes all greater than 1.9 (range 1.9—3.5).  Of note, simulators obtained a significantly 
lower DRV subscale relative to the DRA and PA subscales than normal controls.  
Examining these simulation data in comparison to an early dementia group (N = 8, only) 
demonstrates g effect sizes ranging from 0.9 to 1.8.  Here, simulators appeared to 
overestimate the ability of mildly demented individuals on the PA subscale; the author 
deems this the "Pinocchio Effect" due to the pointed appearance of the aggregated 
simulators' profile.  This has reportedly been replicated in an evaluation of NV-MSVT 
evaluees failing the TOMM and WMT. 
 Despite current shortcomings and lack of validation, the NV-MSVT was selected 
for inclusion in the present study for a number of reasons.  First, it is the shortest 
computerized measure known to the primary investigator, requiring only 6 minutes of 
administration time (not including the 9 minute delay).  It is believed that clinicians 
would find computerized measures significantly more appealing than those involving 
time-consuming administration.  In addition, it may be that those individuals intent on 
feigning may do so more readily when they do not have to provide their response to a 
clinician.  Thus, this test has potential to separate honest and feigning evaluees.  This 
measure was also very appealing because it seems to be particularly susceptible to errors 
associated with poor self-monitoring (i.e., impulsivity or perseveration).  Impulsive 
responses  may occur  when an evaluee is in the habit of responding using quick mouse 
clicks, and selects the wrong response by (a) clicking the mouse twice concurrently 
before even "seeing" the next presentation (motor impulsivity), (b) selecting the option 
on the same side as the previous correct response after noting the correct response, but 
without moving the mouse over that response (general impulsivity), or (c) clicking the 
option on the same side as the previous correct response after having multiple correct 
selections on that side of the screen in a row, but before processing which is correct 
(perseveration).   
Psychiatric Feigning Measure  
Because feigning strategies of students seeking a diagnosis of ADHD are not  
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 well-understood, it is unknown if false psychiatric symptoms are commonly presented.   
Thus, the present study included one such measure.  
The M-FAST  
The M-Fast (Miller, 1999) is a 25-item structured interview that was developed to 
aid clinicians in quickly identifying malingered mental illness.  Administration takes 
about five minutes, and scores are provided on seven scales: Unusual Hallucinations, 
Reported Versus Observed Symptoms (assessing symptom reports that do not correspond 
with actual behavior), Extreme Symptomatology (assessing endorsement of a greater 
number or severity of symptoms than actual psychiatric patients), Rare Combinations 
(assessing symptoms that rarely or never coexist), Negative Image (assessing self-
portrayal in an unusually negative light), Unusual Symptom Course (assessing responses 
not reflecting the actual gradual onset of true mental illness), and Suggestibility.   
The M-FAST was chosen for inclusion over other psychiatric feigning measures 
because some of the above scales appeared to correspond to ADHD symptoms.  
Additionally, it seemed that various items on this measure could be applicable to ADHD, 
or could be construed as assessing its symptomatology (e.g., "I often have a hard time 
sitting still;" "Whenever I sit in a chair I have to breathe deep breaths in order not to get 
sick;" "Sometimes I hear a radio playing when there is not one on near me"—the latter 
corresponding to media reports that some peoples' mental ADHD experience is like a TV 
changing channels).  Unfortunately, there are no known studies of the M-FAST's utility 
in ADHD evaluations; instead, research to date has been limited to general psychiatric 
and forensic samples.  This is summarized in Table 1-3 below. 
M-FAST development and validation were completed using 546 forensic 
psychiatric inpatients and undergraduates.  It was found to have good convergence with 
the gold standards of the time: the MMPI-2 fake bad indices and the Structured Interview 
of Reported Symptoms (SIRS; Rogers, Gillis, Dickens, & Bagby, 1991).  Using the 
MMPI-2 defensiveness and "good impression" indicators, discriminant validity was also 
demonstrated.  Lastly, the M-FAST was found to have strong reliability (alpha = .94, 
test-retest reliability = .91, p < .001).  A brief review of the available known groups and 
clinically enhanced simulation studies is provided in Table 2-1 below.  All studies 
utilized forensic or psychiatric patients, which limits generalizability to the present 
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Table 2-1 
 
Summary of Known-Groups and Clinically Enhanced M-FAST Evaluations 
Reference Des Group N Sample 
MAL-
HON  g
cut 
score Sn Sp 
         
Miller, 1999 a KG MAL 14 FP - .86  
  HON 36 FP  > 9  .83 
         
Guy & Miller, KG b MAL 21 FP .86  
  2004 a  HON 29 FP 1.9 > 6  .83 
         
Miller, 2004 a KG b MAL - FP - .93  
  HON - FP  > 6  .83 
         
Jackson,  KG b MAL 8 FP  
Rogers, &  HON 41 FP 2.8 .76 c
Sewell, 2005 ES MAL 43 FP  . 90 c
  HON 96 FP 1.9 
> 6 
  
         
Veazey, 2005  KG d MAL 5 IP .80  
  HON 39 IP - > 6  .85 
         
Guy, Kwartner ES e MAL 48  Students .88  
  & Miller, 2006  HON 48 Scz 2.7 > 6  .82 
 ES e MAL 41 Students .84  
  HON 20 BP 
1.4 > 6 
 .79 
 ES e MAL 51 Students .62  
  HON 25 MDD 
1.7 > 6 
 .79 
 ES e MAL 50 Students .63  
  HON 47 PTSD 1.2 > 6  .85 
         
Alwes, Clark,  KG MAL 75 CF, P > 6 .83  
Berry, &  HON 178 CF, P 1.0   .91 
Granacher,  KG MAL 23 CF, N > 6 .43  
2007  HON 172 CF, N 3.0   .88 
Note. g = Hedges’ g effect size.  Effects calculated using means and standard deviations, except for 
Guy & Miller (2004), using t-score results.  No study reported feigning incentive.  Only Jackson, 
Rogers & Sewell (2005) provided a warning to feigners and a compliance check.  - = missing or 
unable to determine; BP = bipolar disorder patients, CF = civil forensic (outpatient), Des = design, 
ES = clinically-enhanced simulation design; FP = forensic (imprisoned) psychiatric, IP = inpatient 
psychiatric, KG = known-groups design; N = neurological claim, n/a = not applicable, P = 
psychiatric claim, Scz = schizophrenic patients, Sn = sensitivity, Sp = specificity. 
a It is unclear if there was participant overlap in these three studies, which used the same classif-
ication criteria but reported a slightly different demographic makeup.  Most likely, Miller (2004) 
provides data from Miller (1999).  b SIRS used for classification.   c Values derived from com-
bination of the two studies.  d PAI Malingering Index used for classification.  e Each clinical group 
had a corresponding feigning group, so no two effect sizes or test parameters were drawn from the 
same individual. 
 student and ADHD sample.  However, a very large mean g was demonstrated after 
correcting for sample size (g = 1.7).  Using a cutting score of > 6, sensitivity across 
studies was moderately high at .77, and specificity was moderate at .84. 
Scoring and Data Entry 
 All measures were scored according to standardized instructions.  The Stroop was 
additionally scored with the literature-recommended time per item score.  Scoring and 
data entry were independently cross-checked for accuracy by two individuals at the con-
clusion of data collection.  Review of twenty percent of files resulted in an inter-rater 
reliability greater than 99% (due to seven errors), so no additional files were checked.   
Manipulation Checks
 Two manipulation checks were employed.  In the first, individuals’ post-test 
questionnaires were examined to determine if they accurately summarized instructions 
(e.g., “to fake ADHD” or “to take these tests honestly and with my best effort”) and 
reported providing adequate effort according to a Likert rating of at least three out of five 
points.  The second manipulation check involved assessing group accuracy.  HON and 
ADHD results were examined to determine if they diverged; that is, to support the 
clinical nature of that experimental group.  These results are provided in the next section.
Copyright © Myriam J. Sollman 2008 
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 Chapter Three:  Results 
Sample Description 
A total of eighty undergraduates from the University of Kentucky participated in 
the study.  Of these, seven were excluded for various reasons: two Honest-role subjects 
were non-native English speakers and struggled with the protocol, one Feigning-role 
participant did not pass the post-test by rating effort at least three out of five, and four 
ADHD participants did not provide evidence for a valid diagnosis of the disorder (by 
clinically elevating at least one ADHD-diagnostic measure).  No HON student elevated 
any measure or subscale believed to be “diagnostic” of inattention.  Thirty FGN, twenty-
nine ADHD, and fourteen HON participants remained.  (The HON control group served 
simply as a manipulation check, described later, so few participants were needed).  
Demographics are provided by group in Table 3-1.  As can be seen, the groups were 
equivalent in terms of gender, age, number of months of college, ethnicity, handedness, 
and WTAR-estimated FSIQ.  Overall, this university sample represents a younger under-
graduate group with an Average-range mean WTAR predicted FSIQ of 105.4 (SD = 8.1).   
 Because not all ADHD students were completely sure of their current diagnostic 
subtype, this was estimated by scoring the ARS and CAARS:S—L symptom checklists 
according to manualized instructions.  Based on these results, the ADHD group is best 
described as predominantly Combined subtype (about 75%), with a substantial group 
being Inattentive (>20%), and a minority being Hyperactive-Impulsive (<5%), according 
to symptom reports.  There were two modal ranges of age at diagnosis: 8-12 and 16-18, 
representing 31.0% and 34.4% of the sample, respectively, though the overall range of 
age at diagnosis spanned from four to twenty-one.  The majority of ADHD students 
(41%) were diagnosed using a brief neuropsychological assessment (including 
psychological, IQ, and learning disability testing), while 31% received a full neuro-
psychological evaluation and 21% received a comprehensive psychological evaluation 
including corroborative interviews of parents and teachers.  A minority were diagnosed 
using methods not meeting the above classification (e.g., psychological evaluation and IQ 
testing only).  With regard to treatment, almost one-fifth of the students (17.9%) reported 
using behavioral techniques rather than medication due to side effects.  For those who 
provided  a description of their medication (N = 21), the majority received a form of 
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 Table 3-1 
Demographic Characteristics of Participants Included in Final Analyses 
 
    
 Group   
     
HON FGN ADHD Variable N = 14 N = 30 N = 29 F or χ
2 p
      
Male           % 50.0 46.7 55.2 0.430 .807 
      
Age                           M 18.9 19.1 19.4 1.209 .304 
SD 1.03 1.28 1.21    
      
Months of College M 12.3  13.2  16.3  0.787 .459 
 SD 10.25 10.56 12.89   
      
Race/Ethnicity Overall    8.599 .197 
      
    Caucasian % 100 83.3 86.2 - - 
      
    Black % 0   6.7  6.9 - - 
      
    Asian  % 0 10.0  0 - - 
      
    Multiracial % 0 0  6.9 - - 
      
Right-handed % 85.7 90.0 93.1 0.605 .739 
      
WTAR est. FSIQ M 105.8  105.8 105.6  0.036 .965 
 SD 8.15  8.15 8.54   
      
 
Note.  HON = Honest, FGN = Feigning, WTAR est. FSIQ = Wechsler Test of Adult Reading 
estimated Wechsler Adult Intelligence Scale—III Full Scale IQ. 
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 Adderall (57.8%), and about half (48.3%) were treated with an extended release 
medication.  The accuracy of these reports was not verified by checking medical records.   
Comparison of results from the HON and ADHD groups, as illustrated throughout 
the Results section below, indicated that ADHD participants’ results diverged from those 
of the normal HON group.  This reflects global symptom report and performance 
differences between the presumably clinical participants and the undiagnosed, 
presumably normal students, and loosely supports both the validity of the ADHD group 
makeup and the validity of measures used to distinguish these groups.      
Results from Core Battery 
Data Presentation and Analytic Strategy 
In order to facilitate clarity in data presentation and analyses, the following 
structure will be broadly followed:  First, for each instrument, between group analyses of 
major indices will be undertaken using ANOVA or Mann-Whitney U as appropriate.  
Next, in order to evaluate whether feigning actually occurred, results from the HON and 
FGN groups will be contrasted.  Following this, to assess feigning success, the ADHD 
and FGN groups will be compared.  Then, in order to evaluate individual classification 
rates, slightly different analyses will be undertaken for the ADHD-diagnostic vs. 
malingering measures.  For the ADHD-diagnostic indicators, Sensitivity and Specificity 
rates for the contrasts of HON vs. ADHD will index diagnostic properties, whereas the 
same parameters for the ADHD vs. FGN comparison will illustrate potential error rates in 
settings that have a mixture of feigning normals and genuine  ADHD evaluees.  For the 
malingering indicators, the diagnostic parameters will be presented only for the ADHD 
vs. FGN contrast, as these are the operating characteristics of most interest in the present 
study.  Finally, in a later section, logistic regression will be employed to determine the 
optimal combination of indicators for identification of ADHD vs FGN status. 
 Attention-Related Measures 
CAARS—S:L :  Results are provided in Table 3-2.  One-way ANOVAs indicated 
a significant main effect for group on every measure from this instrument.  Follow-up 
pairwise comparisons using Tukey's HSD at p < .05 identified a consistent pattern across 
all scales, such that the FGN group was statistically significantly higher than the HON 
group and the FGN group was comparable to the ADHD group. The former results 
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 Table 3-2 
CAARS—S:L Scale T-scores (M [SD]) 
 
 Overall  
 
 FGN-ADD HON FGN ADHD 
 
N = 14 N = 30 N = 29 Variable F
 
 p
 
 
  
U p
 
 g 
  
           
 49.9   (7.11) a  71.0  (10.43) b  66.9 (12.23) b Scale 1  19.140 .000  354.5 .222  0.36 
           
 44.9   (8.73) a  66.7    (8.80) b 
   
 63.9   (9.38) b Scale 2  29.853 .000  360.0 .255  0.31 
        
 42.7   (6.84) a  64.1  (12.19) b 
   
 59.7 (12.34) b Scale 3  17.042 .000  358.5 .246  0.36 
        
 43.7   (7.25) a  55.2  (10.20) b 
   
 53.3 (10.53) b Scale 4    6.761 .002  396.0 .554  0.18 
        
 51.9 (10.06) a  79.4    (9.43) b 
   
 79.6 (11.20) b Scale 5  40.705 .000  432.5 .970 -0.02 
        43  42.1   (8.43) a  72.0  (11.00) b  69.9 (12.48) b Scale 6  38.014 .000  381.5 .417  0.18 
           
 47.1   (9.65) a  80.2    (9.49) b 
   
 78.5 (10.11) b Scale 7  61.818 .000  395.0 .543  0.18 
        
 45.4   (9.47) a  67.0  (11.54) b 
   
 63.6   (9.90) b Scale 8*  20.952 .000  356.0 .320  0.31 
        
 46.0   (0.45) a  69.5    (8.84) b 
   
 66.9   (8.27) b Overall Mean  40.671 .000  386.0 .453  0.30 
        
   0.1   (0.27) a    5.1    (2.33) b    4.6   (2.23) b Number of Scales > 65T  31.088 .000  363.5 .278  0.21 
           
 
Note.  Within each row, columns with different letters are statistically different (p < .05) from one another according to Tukey post-hoc testing.  
FGN-ADHD = comparisons involving those groups only; g = Hedges’ g effect size; Overall = comparisons involving all three groups.
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 suggests that analog feigners endorsed symptoms at a significantly higher rate than 
control participants; the mean elevations here are mostly in the clinically significant 
range according the manual for the test (i.e., > 65T).  The non-significantly different 
scores for the FGN and ADHD contrasts suggest that feigners approximated the symptom 
reports of students diagnosed with ADHD.  This lack of difference is also illustrated by 
the rank distribution of scores for the FGN and ADHD groups according to the Mann-
Whitney U Test, which reflects a comparable number and degree of elevated scores for 
those groups.  Further, the median FGN-ADHD contrast g was .18, which barely approx-
imates a small effect size.  These results suggest that normal students could easily feign 
ADHD symptoms on the CAARS-S:L to a comparable extent to those with the diagnosis. 
Table 3-3 presents Sensitivity and Specificity values of the CAARS—S:L  for 
distinguishing HON and ADHD as well as FGN vs. ADHD contrasts.  Results indicate 
perfect Specificity for the HON vs. ADHD contrast, but only modest Sensitivity (median 
= .586).  Findings were considerably worse for the FGN vs. ADHD contrast.  Here 
Specificity calculated using FGN results was very poor (median = .650), although 
Sensitivity remained moderate (median = .350) as it was calculated using the same 
ADHD group as in the previous contrast.  Overall, these results suggest that the CAARS-
S:L is modestly effective at discriminating honestly responding students with ADHD 
versus honestly responding normals.  However, the instrument is essentially unable to 
distinguish normals feigning ADHD from those with the condition who responded 
honestly.  In this regard, it should be noted that the CAARS—S:L has not been 
previously validated for discrimination of feigned vs genuine ADHD. 
CAARS—S:L additional considerations:  In clinical evaluations of the 
CAARS—S:L, the authors suggest that two factors be considered when determining if a 
profile is clinical or not:  performance on Scale 8, and the number of scales elevated.  As 
with the other scales, a T-score greater than 65 is considered clinically noteworthy on 
Scale 8.  In the present sample, the ADHD mean score’s 95% confidence interval did not 
fall entirely within the range of clinical elevation, though the average and score 
distribution were not statistically different from that of the FGN group, which was 
clinically elevated.  As such, Scale 8 may not be the most robust index of clinical status 
for undergraduates.  A sensitivity value of .448 furthers this contention.   
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 Table 3-3 
Clinical Elevation  on CAARS—S:L Scales (> 65T), By Group 
 
 
 
HON FGN ADHD Sn to 
ADHD 
Sp for 
HON 
Sp for 
FGN N = 14 N = 30 N = 29 Variable 
        
Scale 1 0 22 19  .655 1.000 .267 
        
Scale 2 0 16 15  .517 1.000 .467 
        
Scale 3 0 14 11  .379 1.000 .533 
        
Scale 4 0  6  4  .138 1.000 .800 
        
Scale 5 0 28 27  .931 1.000 .067 
        45 Scale 6 0 22 20  .690 1.000 .267 
        
Scale 7 0 28 25  .862 1.000 .067 
        
Scale 8* 0 17 13  .448 1.000 .433 
        
Ruling Out ADHD:        
        
0—1 Scales Elevated 0  1  3  NR 1.000 .967 
        
Up to 3 Scales Elevated 0 11  7  NR 1.000 .633 
        
Ruling In ADHD:        
        
6—8 Scales Elevated 0 15 12  .414 1.000 .533 
        
4—8 Scales Elevated 0  19 22  .759 1.000 367 
        
 
Note. The condition of interest (for sensitivity) is ADHD.  HON-ADHD = analyses involving those conditions; NR = not relevant; Sp = 
Specificity; Sn = Sensitivity; *The test manual recommends that Scale 8, and the number of scales with clinical elevations (>65T), be examined 
when making a diagnostic decision.
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 Turing to the number of scales elevated above 65T, the test manual does not 
provide a guideline regarding the number of scales that should be elevated for a clinical 
determination.  In this study, the FGN and ADHD groups produced equivalent numbers 
(ADHD M = 4.6 [SD = 2.23], FGN M = 5.1 [SD = 2.31]) and distributions (U = 363.5, p 
= .278) of elevated scales (see Table 3-2).   This suggests that it does not discriminate 
feigned from diagnosed ADHD.  However, because a clinically significant profile was 
required on at least one of the ADHD-diagnostic measures for ADHD participants to 
remain included in the study (as stated earlier), this may be biased. As depicted in Table 
3-3, though more than four elevations pointed to attention dysfunction in this sample 
(Sensitivity = .759, Specificity for HON = 1.000), it did not distinguish feigned from 
actual attention problems (Specificity = .367). 
 ARS:  This measure is scored differently from the Conners’ scales, as raw scores 
are interpreted in light of gender-based cut scores. As such, it was necessary to analyze 
data for males and females separately.  Univariate ANOVA was used for this task to 
examine for main effects of gender and role, as well as an interaction of the two.  ARS 
endorsements for the Childhood and Current Symptoms scales are provided in Table 3-4, 
collapsed across gender for simplicity.   
Overall, results closely matched those of the CAARS-S:L. There was a significant 
main effect for group on every index, which according to follow-up contrasts using 
Tukey HSD at p < .05 indicates that the FGN group endorsed significantly more items in 
a “clinical” manner (by rating them 2 or 3)  than the HON group.  Also, the FGN group 
endorsements were similar to the ADHD group’s for every subscale.  Analog feigners’ 
endorsements were generally consistent with clinical elevation, for both males and 
females.  Collapsed by gender, effect sizes for the Inattentive and Hyperactive subscales 
were small for all scales (median g = .31), but were larger on those subscales were gender 
effects were noted due to the tendency of female feigners to rate more symptoms 2 or 3. 
These included both Childhood subscales, as indicated with footnotes in Table 3-4 below. 
Table 3-5 presents sensitivity and specificity values of the ARS for distinguishing 
HON and ADHD as well as FGN vs. ADHD contrasts.  Just as with the CAARS:S—L, 
results indicate perfect specificity for the HON condition when contrasted with ADHD.  
Sensitivity to ADHD was somewhat higher (mean = .785) for this measure.  Specificity
 46  
 Table 3-4 
Barkley-Murphy ARS Test Results Collapsed Across Gender: Number of Clinically Relevant 
Endorsements (M [SD]) 
 
FGN-
ADHD HON FGN ADHD Overall  
Variable (Cut Score) N = 14 N = 30 N = 29 p g 
 
     
     
Current Scale 
      
.5 (1.16) a   6.4 (2.66) b   5.5 (2.60) b .000 .31 Inattentive  (> 4)  
      
Hyperactive  (> 5) .3 (0.61) a   5.7 (2.48) b   5.3 (2.25) b .000  .18 2
      
.8 (1.48) a 12.1 (4.88) b 10.8 (4.19) b Total (NA) .000 .15 
      
      
Childhood Scale      
      
Inattentive  (M>7, F>6) 1.2 (1.53) a   7.3 (2.26) b   7.0 (2.06) b .000  .49 3
      
Hyperactive (M>7, F>6) 1.0 (1.71) a   7.4 (2.14) b   6.6 (2.18) b .000  .44 4
      
Total  (NA) 2.2 (3.02) a 14.7 (4.10) b 13.6 (3.60) b .000  .36 5
      
      
Est. Age Onset (NA) - 7.0 (2.25) 7.5 (4.03) .768  -.20 6
      
 
Note.  Data were analyzed using Univariate ANOVA due to lack of gender norms. Means and 
effect sizes collapsed by gender for this table, though analyses produced separate results. Means 
represent the number of items endorsed two or three on a Likert spanning from zero to three.  
Statistics provided for FGN-ADD contrast.  Within each row, columns with different subscripts 
are significantly different, p < .05, according to post hoc testing.  Gend = gender; Grp = group; 
Intxn = interaction; mean g = average Hedge’s g effect size indicator (combined for males and 
females); M = male; F = female.    
1 Gender effect reflects that males’ scores were lower than females’ scores.  2 Male g = -.04, 
Female g = .39.  3 Male g = -.31, Female g = .66.  4 5 Male g = .00, Female g = .87.   Male g = -.16, 
Female g = .87. 6 Male g = -.46, Female g = .07.
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 Table 3-5 
Frequency of Clinical Classification on ARS Indices, Using Age and Gender-Based Norms (Murphy & Barkley, 1996) 
 
        
 HON FGN 
(N = 14) (N = 30) 
   
ADHD Sn to 
ADHD 
Sp for 
HON 
Sp for 
FGN  (N = 29) 
     
       Current Symptoms Scale   
        
Inattentive Endorsements 0 24 24  .828 1.000 .200 
        
Hyperactive Endorsements 0 18 19  .655 1.000 .400 
        
Current Symptom Clinical Classification * (0) (24) (25)  .862 1.000 .200 
    
   
    
     Inattentive 0 6 6  - - - 
        
     Hyperactive 0 0 1  - - - 48         
     Combined 0 18 18  - - - 
        
        
Childhood Symptoms Scale        
     
.759 1.000 .167 Inattentive Endorsements 0 25 22  
        
.897 1.000 .333 Hyperactive Endorsements 0 20 26  
        
Childhood Symptom Clinical Classification * (0) (28) (26)  
 
.897 1.000 .067 
   
   
   
 
     Inattentive 0 2 6  - - - 
        
     Hyperactive 0 3 4  - - - 
        
     Combined 0 23 16  
 
- - - 
    
 
 
Note.  Endorsements refer  to items rated 2 or 3 on the 0—4 Likert.   *Values in parentheses represent total of individuals meeting classification 
criteria for Inattentive, Hyperactive, or Combined subtype.
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 in the FGN-ADHD contrast was poor for this measure (mean = .275), indicating that it 
essentially does not discriminate between normals feigning ADHD and ADHD patients 
responding honestly.  However, as with the CAARS—S:L , the ARS has not been 
previously validated for discrimination of feigned vs genuine ADHD.  
Additional ARS Considerations:  On the ARS, individuals are additionally 
asked to estimate the age of onset of the rated problems.  Participants in the FGN and 
ADHD groups reported comparable symptom onset ages (overall M = 7.0 [SD = 2.25]), 
with no main effects or interactions for gender and role.  It should be noted that coaching 
material provided the DSM-IV criterion that symptoms must be present before age seven.   
ARS-identified subtypes are explored later under the heading of Feigning Strategies. 
Continuous Performance Test:  C-CPT results are provided in Table 3-6, and 
diverge somewhat from the results of the Symptom Report measures described above.  
Although there were significant main effects of group for several indices, neither the 
number of perseverations, Hit Rate, Beta, nor any variable examining changes across 
response block or stimulus item showed an effect.  (Note that Hit Rate and Beta were 
examined as two-tailed indices due to clinical scores being <35T and >65T).  This calls 
into question the validity of these variables for distinguishing clinical versus normal 
individuals, so they will not be discussed further. Of further concern, of those seven 
variables with a significant main effect of group, follow-up pairwise contrasts revealed 
no significant difference between HON and ADHD for five; and, for three (Omissions, 
Hit Rate SE, Variability), the FGN group was significantly higher than the ADHD group.  
In fact, the ADHD group did not have a mean above the clinical cut score (65T) on any 
index. 
Table 3-7 presents sensitivity and specificity values of the CAARS—S:L  for 
distinguishing HON and ADHD as well as FGN vs. ADHD contrasts.  For the selected 
indices that showed a main effect of group in the previous analyses, these results indicate 
near-perfect specificity for HON vs. ADHD (median Sp = .714), and low to moderate 
Specificity for FGN vs. ADHD (median = .621).  Not surprisingly, though, Sensitivity to 
ADHD was very poor (median = .241).  Overall, these results suggest that the C-CPT is 
ineffective in identifying undergraduates with ADHD, relatively good at ruling out 
symptoms in normals presumed to be performing to the best of their ability, but poor at 
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Table 3-6 
Conners’ CPT T-scores for Indices Where T > 65 is Indicative of Clinical Profile 
 
 
 
Overall  
 
FGN-ADD 
Variable 
 
HON 
N = 14 
FGN 
N = 30 
ADHD 
N = 29 
 
 
F 
 
p 
  
U 
 
p 
 
g 
 
           
Index T-scores           
           
  Omissions  46.4   (4.24) a  85.4 (46.01) b  61.2 (24.15) a    7.596 .001  301.0 .042 0.65 
           
  Commissions   48.2 (14.67) a  63.5 (10.02) b  59.5   (9.93) b    9.319 .000  351.0 .203 0.40 
           
  Hit Rate SE  50.5   (9.56) a  70.4 (17.48) b  60.0 (15.81) a    8.419 .000  283.5 .022 0.62 
           
  Variability  49.8   (8.62) a  67.5 (13.09) b  58.2 (13.77) a  10.099 .000  257.0 .007 0.70 
           
  Detectibility  50.6   (8.63) a  59.4   (5.43) b  57.4   (6.90) b    8.280 .000  351.0 .203 0.31 
           
  Perseverations  48.3   (5.51)   81.7 (91.50)   61.3 (26.03)    1.641 .201  347.5 .181 0.30 
           
  Hit Rate Block Change  48.3   (7.56)  52.2 (12.95)  47.4 (12.15)    1.332 .270  367.5 .306 0.38 
           
  Hit Rate SE Block Change  55.8   (7.94)  53.5 (13.09)  52.2 (10.17)      .480 .621  420.5 .826 0.11 
           
  Hit Rate ISI change  58.8  (12.40)  67.7 (19.89)  61.6 (17.32)    1.603 .209  355.0 .225 0.33 
           
  Hit Rate ISI SE change  53.3   (9.40)  62.6 (15.44)  58.2 (11.97)    2.488 .090  375.0 .363 0.31 
           
Number Scales >65T    1.1   (1.56) a    3.9   (2.98) b    2.3   (2.44)      6.362 .003  296.0 .033 0.58 
           
“% Clinical Agreement”  42.4 (17.76) a  71.4 (26.40) b  60.3 (24.04)      7.005 .002  327.5 .090 0.44 
           
Note.  Within each row, columns with different letters are statistically different (p < .05)  from one another according to Tukey post-hoc testing.  
“Hit Rate” and “Beta”  not provided because distributions are binomial due to clinical scores being <35T and >65T; using Univariate ANOVA 
no main effect of group observed.  FGN-ADHD = comparing those groups only; g = Hedges’ g effect size; Overall = comparing all three groups.
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 Table 3-7 
Frequency of Clinical Elevation on C-CPT subscales, for Those with Group Differences 
 
 
Sn to 
ADHD 
Sp for 
HON 
Sp for 
FGN 
HON FGN ADHD 
(N = 14) (N = 30) (N = 29)  
        
Mean Index Score >65T 0 14 7  .241 1.000 .533 
        
        
Index        
        
   Omissions  0 14 7  .241 1.000   .533 
        
   Commissions  2 12 9  .310   . 857   .621 
        
   Hit Rate * 4   9 7  .241   .714   .724 
        
   Hit Rate SE  0 18 7  .241 1.000   .400 
        
   Variability  1 16 7  .241   .929   .483 
        
   Detectibility 1   4 5  .172   .929   .897 
        
   Beta * 0   0 0  .000 1.000 1.000 
        
 
Note.  *Clinical elevation at >65T, except Beta and Hit Rate, where clinical at <35T and 
>65T.  Subscales indicative of inattention include Omissions, Hit Rate Block Change, and Hit 
Standard Error Block Change.  Subscales indicative of hyperactivity/impulsivity include 
Commissions, Perseverations, and Hit Rate (using values <35T for the latter).   NA = not 
applicable because bi-directional test not possible; ns = not significant; Sn = sensitivity to 
ADHD, Sp = specificity.    
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 avoiding false positive diagnoses for FGN.  Overall, individuals in this sample with 
clinical elevations are likely to be FGN-role.   
Additional C-CPT Considerations:  The variable “Percent Clinical Agreement” 
(presented in Table 3-6) indicates the percent correspondence between an individual’s 
profile and the standardization sample’s  mean clinical profile.  It is the first information 
provided in a C-CPT report, suggesting it is believed to be a good overall indicator of 
attention dysfunction status.  On this variable, the FGN group obtained a mean clinical 
profile agreement of 71.4% (SD = 26.40).  According to post-hoc analyses, this value was 
significantly different from that of the HON group, which obtained a high mean clinical 
profile agreement of 42.4% (SD = 17.76).  The mean ADHD group Percent Clinical 
Agreement  was not different from either FGN or HON, and fell at chance (50%). 
Summary of ADHD-Diagnostic Results:  In summary, both symptom checklists 
administered (the CAARS:S—L and the ARS)  were highly unlikely to classify normals 
responding honestly as ADHD and were relatively sensitive to ADHD, but were very 
easily faked. At published cutting scores, the C-CPT indices were insensitive to the 
attention dysfunction of the ADHD group.   
Results of Standard Neuropsychological Testing 
 Three neuropsychological tests were administered: the Nelson-Denny  
Comprehension subtest Reading Speed component (N-D Comp), the Stroop Color-Word 
Test (Charles Golden Version, 2002), and the WMS- III Word Lists Immediate subscales 
(WMS-III WL).  Because no cut scores are available for these measures, sensitivity and 
specificity are not explored. 
 N-D Comp Results:  Students were administered the N-D Comp with instructions 
to read at their usual rate, “for comprehension.”  There was no between-group difference 
in either reading rate (Overall, F(2) = 1.360, p = .393) or in the distribution of reading 
times, after removing three outliers that were each more than three standard deviations 
above the mean.  Thus, all three groups read comparable numbers of words.  On average, 
the HON group read 188 words per minute (SD = 40.8),  feigners read 182 (SD = 42.1), 
and ADHD read 167 (SD = 46.1).  Thus, this component of the test has little diagnostic 
utility in ADHD undergraduates.   
Stroop Task Results:  For each Stroop subscale (Word, Color, and Color-Word),  
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 three types of scores were calculated: T-scores according to instructions within the 
manual, words read per second, and errors per subscale.  T-scores account for errors via 
increased reading time. These results are presented in Table 3-8 and discussed separately.   
Regarding the Subscale T-scores, lower scores are more indicative of pathology.  
Here, significant main effects of group are seen for all indices except the controversial 
Interference score discussed earlier.  For those with group differences, follow-up pairwise 
comparisons indicate that the FGN group read significantly slower than the HON group 
for all.  The FGN mean was significantly lower than ADHD group mean only on the 
Word subtest, where significantly more feigners scored in the impaired direction.  This is 
supported by a large FGN-ADHD effect size (g = -1.06).  The HON and ADHD groups 
had equivalent mean T-scores on all subtests, indicating that theses indices were 
insensitive to difficulties associated with ADHD.  
Examining the mean number of words read per second, previously suggested to 
be a more accurate indication of reading speed, the resulting patterns and effects were 
identical to the above.  This suggests that the scoring methods are comparable in these 
samples.  In combination with results from the Nelson-Denny Reading Test, it 
additionally suggests that ADHD undergraduates do not read significantly slower than 
presumed normal students. 
Turning to the raw number of errors, main effects of group were observed for the 
Word and Color subtests. Follow-up tests reveal different patterns of results, however.  
On the Word subscale, feigners provided more errors than presumed normals.  However, 
there were statistically equivalent numbers and distributions of errors for the FGN and 
ADHD groups.  This is supported by the only moderate effect size, .48.  Of note, the 
ADHD group did not achieve significantly  more errors than the HON group.  On the 
Color subscale, the FGN group again produced more errors than the HON group; but the 
FGN group also more errors than the ADHD group, resulting in a slightly larger effect 
size for this contrast (g = .63). Again, the ADHD and HON groups were statistically 
equivalent.  
WMS-III WL Results:  The WMS-III WL was scored according to manualized 
instructions, to produce various index Scaled Scores (as well as feigning indices 
described later).  These results are presented in Table 3-9, and show a main effect for
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Table 3-8 
 
Stroop Test Results (Mean [SD])  
 
 
 
Overall  
 
FGN-ADD 
Variable 
 
HON 
N = 14 
FGN 
N = 30 
ADHD 
N = 29 
 
 
F 
 
p 
  
U 
 
p 
 
g 
 
           
Subscale T-score           
           
     Word    48.3  (13.96) a     30.9 (12.18) b     43.0 (10.65) a  12.752 .000  198.5 .000   -1.06 
           
     Color    47.1  (10.23) a     37.5 (11.51) b 43.2   (9.92)    4.419 .016  309.0 .056   -0.53 
           
     Color-Word    52.8    (9.52) a     43.2 (12.16) b 47.7   (8.49)    4.427 .018  313.0 .064   -0.43 
           
     Interference    55.4    (5.88)     54.0   (8.67)     53.2   (7.14)      .391 .678  412.0 .727    0.10 
           
           
Mean Words / Second           
           
     Word  2.3 (.46) a 1.7 (.40) b 2.1  (.36) a  12.133 .000  194.0 .000  -1.05 
           
     Color  1.7 (.28) a 1.4 (.31) b 1.6  (.26)     4.388 .016  308.5 .055  -0.70 
           
     Color-Word  1.1 (.23) a 0.9 (.27)  b 1.0  (.19)     4.348 .017  307.0 .052  -0.43 
           
   
        
Raw Number Errors           
           
      Word Errors       0.0 (.00) a 1.0 (1.89) b      0.3  (.55)     3.586 .033  378.0 .303   0.48 
           
      Color Errors 0.1 (.27) a 1.0 (1.54) b      0.2  (.51) a     5.005 .009  338.5 .058   0.63 
           
      Color-Word Errors       0.4 (.65)      1.0 (1.40)       0.6  (.91) 
 
    1.065 
 
.350  417.0 
 
.755 
 
  0.26 
       
 
 
 
Note.  Within each row, columns with different letters are statistically different (p < .05)  from one another according to Tukey post-hoc testing.   
FGN-ADD = statistics involving only those participant groups; Overall = statistics involving all three participant groups.
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Table 3-9 
 
WSM-III Word Lists Results   
 
 
Overall  
 
FGN-ADD 
Variable 
 
HON FGN ADHD 
 
 
F 
 
p 
  
U 
 
p 
 
g 
 
           
Subscale Scaled Score: N = 14 N = 30 N = 29        
           
     1st Recall       11.1 (3.08)      9.4  (2.16)       9.4 (3.03)  2.130 .126  416.5 .775  0.00 
           
     Recall Total      11.4  (2.47) a      7.8  (2.86) b       9.0 (2.73) b  8.073 .001  320.0 .079 -0.43 
           
     Learning Slope        9.5  (2.65)      8.2  (2.16) a     10.1 (3.74) b  2.896 .062  300.0 .038 -0.60 
           
     Contrast 1        9.6  (2.13)      9.7  (2.13)     10.4 (2.81)  .680 .510  351.5 .199 -0.29 
           
     Contrast 2  10.1  (3.23) a 7.7  (3.49) b 10.5  (2.36) a  6.738 .002  232.0 .002 -0.92 
           
           
Pilot Variables:           
           
Number of Intrusions* N = 14 N = 30 N = 29        
           
 0.1 (.27) 1.0 (1.81) 1.0 (1.20)  2.426 .096  388.5 .439 -0.02 
           
           
Number of Repetitions* N = 5 N = 11 N = 24        
           
 2.0  (2.55) 
 
1.2  (1.40) 2.9  (2.89)  1.719 .193  230.5 .000   0.67 
          
 
 
Note.  Within each row, columns with different letters are statistically different (p < .05)  from one another according to Tukey post-hoc testing.   
FGN-ADD = statistics involving only those participant groups; Overall = statistics involving all three participant groups.
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 group on only two of the five variables: Recall Total (sum of words recalled in Trials 1 
through 4) and Contrast 2 (difference in number of words recalled in Trial 4 and the Short 
Delay).  For Recall Total, pairwise post-hoc tests indicate that the FGN group recalled 
significantly fewer words than the HON group and an equivalent number to the ADHD 
group.  This is supported by a relatively small effect size in the FGN-ADHD contrast (g = 
-.43) and a lack of difference in the distribution of FGN and ADHD scores.  The ADHD 
group was equivalent in performance to the HON group, suggesting this is not an area of 
difficulty for this clinical sample.  For the Contrast 2 variable, feigners achieved signif-
icantly lower scores due to recalling fewer words at the Delay than both HON and 
ADHD groups, whose recalls were statistically equivalent (Tukey HSD p = .002; Mann 
Whitney p = .002).  These results suggest that Contrast 2 is likely the most effective at 
discriminating feigned from honest performance, according to the large FGN-ADHD g of 
-.92.  However, the WMS-III WL subtests are broadly ineffective at separating 
performance of ADHD from normal students responding honestly. 
For this study, the total number of intrusions provided across all learning and 
recall trials was recorded to determine if this variable discriminate feigned or genuine 
ADHD from presumed normal honest performance.  There were no between-group 
differences, precluding this notion. There was likewise no effect in the FGN-ADHD 
contrast  (g = -.02). In addition to the number of intrusions, the number of repetitions was 
recorded for a minority of participants.  Power to detect a difference is minimal, and no 
main effect of group was noted.  However, score distributions indicate that significantly 
more ADHD than FGN participants provided repetitions (U  = 230.5, p = .000), and a 
moderately high effect size of -.67 was observed for this contrast.  Thus, examining 
repetitions may prove helpful in identifying genuine ADHD. 
Neuropsychological Test Result Summary:  Overall, ADHD participants were not 
likely to obtain reduced neuropsychological test scores relative to presumed normals.  
FGN-group performance on neuropsychological testing resembles that of the research on 
feigned head injury (described earlier) in that malingerers’ performance was generally 
suppressed.  However, the size of FGN-ADHD group separation in this study, as 
evidenced by effect sizes, was less than is commonly seen in known-groups assessment 
of neurological insult groups.  Though the nature of this study’s design does not make it 
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 directly comparable to the real-world counterpart (known-groups), the observation 
suggests that undergraduates were successful at making themselves not look too 
impaired, an issue for which they were coached.  This further hints that using neuro-
psychological testing results is unlikely to be as helpful with similar samples.  This issue 
is discussed further in the Classification Accuracy section. 
Feigning Test Results 
Symptom Validity Tests, broadly speaking, were developed to distinguish mal-
ingerers from those with genuine pathology.  Results for the Test of Memory Malingering 
(TOMM), Digit Memory Test (DMT), Letter Memory Test (LMT), Nonverbal Medical 
Symptom Validity Test (NV-MSVT), WMS-III WL Inconsistency Index, Miller Forensic 
Assessment of Symptoms Test (M-FAST), and CAARS—S:L Inconsistency Index are 
provided in Table 3-10, which shows the mean test score for each measure and index.  
Cognitive Malingering Measures:  Very consistent main effects for group were 
demonstrated across all of the cognitive malingering measures (this category excludes the 
M-FAST and CAARS—S:L index), except the WMS-II WL Inconsistency Index for 
which there was no main effect of group.  For those variables with significant main 
effects, post-hoc testing indicated that the FGN group consistently scored significantly 
lower than the HON group, as well as the ADHD group, which was statistically 
equivalent with the HON group. This suggests that the various measures are insensitive to 
problems associated with ADHD in undergraduate samples, but are attuned to 
performance differences associated with feigning.  Indeed, very large effect sizes in the 
ADHD-FGN contrast were noted:  Excluding the Inconsistency Index, the mean 
cognitive feigning measure effect size was g = 1.12.  Additionally, the distribution of 
FGN and ADHD individual scores was characterized by significantly more FGN than 
ADHD individuals producing low scores in each case (see Mann-Whitney p-values). Of 
note, examination of the nature of group means shows that for the TOMM and LMT in 
particular, more feigners scored in the lower range of effort.   
The sensitivity to feigning and specificity for the Honest and ADHD conditions in 
contrast to feigning are provided for the cognitive feigning measures in Table 3-11.  Near 
perfect specificity in the HON vs. FGN contrast was noted across the board at each 
measure’s published cut score (examining the best index per measure, M = .982, Med = 
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Table 3-10 
Feigning Test Results (Mean [SD]) 
 
 
 
Overall  
 
FGN-ADD 
Index (Cut Score) 
HON 
N = 14 
FGN 
N = 30* 
ADHD 
N = 29 
 
 
F 
 
p 
  
U 
 
p 
 
g 
 
           
TOMM Subscales (< 90)           
           
     Trial 1 % Correct 98.6 (2.98) a   76.7  (13.58) b     93.7 (6.30) a   33.722 .000  109.0 .000 -1.60 
           
     Trial 2 % Correct   100.0 (0.00) a    84.5  (17.07) b      99.2 (2.65) a    16.077 .000  147.5 .000 -1.19 
            
     Retention % Correct     99.9 (0.54) a   84.9  (16.08) b     99.2 (2.65) a   16.816 .000  120.5 .000 -1.23 
           
   
           
DMT % Correct (< 90)   100.0 (0.00) a   90.2  (11.83) b 99.5 (1.30) a   13.634 .000  190.0 .000 -1.10 
        
           
LMT % Correct (< 93)   100.0 (0.00) a   85.5  (15.97) b     97.7 (3.35) a   13.667 .000  204.5 .001 -1.06 
           
           
NV-MSVT           
           
     Scale A (< 90) 97.5 (3.25) a    90.5   (9.21) b 97.2 (3.54) a   9.772 .000  215.0 .001 -0.96 
           
     Scale B (< 88) 96.3 (4.66) a 87.0 (12.31) b 96.1 (4.73) a   9.855 .000  216.5 .001 -0.97 
       
   
   
    
        
WMS-LL Inconsistency      0.89 (.067)     0.82 (0.108)      0.87 (.091)   2.863 .064  315.5 .070 -0.46 
        
           
M-FAST Subscales           
           
     RO     .07 (2.67) a  .63 (0.49) b      .34 (0.48) a   7.811 .001  309.5 .028 0.60 
           
     ES       .14 (0.36)       .63 (0.96) a  .14  (0.35) b   4.694 .012  313.0 .017 0.68 
           
     RC .00 (0.00)      .53 (1.22)      .21 (0.56)   2.107 .129  390.5 .320 0.33 
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      UH .00 (0.00)      .40 (0.68)       .21 (0.49)   2.811 .067  376.5 .232 0.32 
              
     USC .00 (0.00)      .27 (0.45)      .14 (0.35)   2.667 .076  379.0 .223 0.32 
           
     NI     .00 (0.00)      .10 (0.31)      .03 (0.19)   1.101 .338  406.5 .321 0.28 
           
     S     .00 (0.00)      .07 (0.25)      .00 (0.00)   1.473 .236  406.0 .161 0.39 
           
    .21 (0.58) a    2.63 (3.03) b    1.07 (1.22) a      TOTAL   7.745 .001  292.0 .025 0.67 
           
           
CAARS Inconsistency     4.0 (2.04)      5.2 (2.25) 
   
     5.2 (2.43)   1.436 .245  431.0 .951 -0.22 
        
 
Note.  Within each row, columns with different subscripts are significantly different according to Tukey post-hoc testing, p < .05.  * 
N = 29 for LMT due to student not finishing protocol before leaving.
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 Table 3-11 
 
Frequency of Probable Feigning  on Symptom Validity Tests 
 
HON FGN ADHD Sn to 
FGN 
Sp for 
HON 
Sp for 
ADHD Index (Published Cut Score) N = 14 N = 30* N = 29 
 
    
  
     
  
TOMM Subscales       
       
     Trial 1 (used < 90%) 0 26 5 .867 1.000 .828 
       
     Trial 2 (< 90%) 0 14 1 .467 1.000 .966 
       
     Retention (< 90%) 0 14 1 .467 1.000 .966 
 
 
      
      
DMT % Correct (< 90%) 0 13 0 .433 1.000 1.000 
       
       
LMT % Correct (< 93%) 0 15 2 .500 1.000 .931 
       
       
NV-MSVT        
       
     Scale A (< 90%)  1 14 2 .467 .929 .931 
       
     Scale B (< 88%) 2 13 2 .433 .857 .931 
       
       
M-FAST Total (> 6) 0 3 0 .100 1.000 1.000 
       
       
CAARS Inconsistency (> 8) 1 5 5 .167 .929 .828 
       
 
Note. WMS-III WL not included because no cut score has been suggested or become 
apparent yet.  n/a =  not applicable due to lack of published cut score; ns = not 
significant, *  = for LMT, FGN N = 29 due to one student having to leave before protocol 
complete. 
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 1.000).  Thus, the cognitive feigning measures are highly unlikely to misclassify a normal 
honest undergraduate performing to the best of his/her ability as feigning.  Very high 
specificity was also noted for the ADHD vs FGN contrast (examining the best index per 
measure, M = .946, Med = .926).  This suggests that none of these measures is likely to 
misclassify ADHD individuals as feigners.  The DMT demonstrated the highest Sp (1.0), 
followed by TOMM Trial 2 and Retention (both Sp = .966).    
While these measures were not developed to identify feigned ADHD or normed 
on ADHD samples to develop optimal cut scores, modest sensitivity was noted across the 
board (M = .567, Mdn = .484).  When a cut score of less than 90% was applied to the 
TOMM Trial 1, it far outperformed the other indices with high sensitivity (.867), though 
with an accompanying lower specificity (.828).   Because of the near-perfect specificity 
described above, high accuracy can be expected when an individual is said to be feigning 
by any measures except the TOMM T1. 
M-FAST:  The psychiatric feigning measure performance was characterized by a 
very low item endorsement rate for all groups.  However, looking at the Total Score 
mean (Table 3-10), there was a main effect of role due to feigners endorsing more items 
than both HON and ADHD participants (per Tukey HSD results).  There was likewise a 
tendency for feigners to provide a greater number of higher-ranked responses than 
ADHD participants (Mann-Whitney results).  A moderately high effect size of g = .67 
was noted. 
As indicated in Table 3-11, the M-FAST demonstrated perfect specificity for both 
the HON and ADHD individuals in this sample, indicating that it did not classify any 
non-feigners as feigning using the standard cut score of six or more endorsements.  
However, it had very low sensitivity—just .100.  Despite the high specificity, the M-
FAST is unlikely to be helpful because of very low sensitivity to feigned ADHD.   
CAARS:S—L Inconsistency Index:  Because it is embedded in the CAARS:S-
L,the results of this measure were examined.   An Inconsistent profile typically results 
from responses that do not consider item content, such as random responses.  Due to the 
academic nature of the sample, this index was not expected to discriminate FGN and 
ADHD groups, so a lack of main effect of group, a low FGN-ADHD effect size  
(g = -0.22, Table 3-10), and very low sensitivity to feigning (.121) are not surprising.   
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 However, HON and ADHD groups’ individual performance on this measure was of 
interest.  The mean Inconsistency score for these groups ranged from about four to five 
items, suggesting that at a cutoff of >8 endorsements, very few if any individuals would 
be classified as inconsistent.  This is reflected in the high specificity for HON, .929 
(Table 3-11) as well as for ADHD, .828, and provides some support for the index’s 
construct validity.   
 Implications and Direction for Symptom Validity Testing Alone:  These results 
suggest that at the published cutting scores, no one symptom validity measure alone 
would be useful for both ruling out feigning in truly honest normal or ADHD evaluees 
and correctly identifying  malingering in other individuals. Should only symptom validity 
tests be used to maximize classification accuracy, the use of two measures may increase 
classification accuracy.  Here, a measure with maximal specificity could be used first to 
ensure Honest individuals are not wrongfully determined to be feigning,  followed by a 
measure with high sensitivity to feigning, yet still adequate Sp.  Using multiple measures 
may also lead to incremental increases in sensitivity.  Based on the above results, use of 
the DMT followed by the TOMM T1 index might be optimal at these cut scores.  This is 
evaluated in more detail subsequently.   
Final Considerations 
Classification Accuracy at the Individual Level 
Of those individuals said to have a condition of interest by a measure at a given 
cut score, the proportion that actually do is represented by the test’s positive predictive 
power (PPP).  Negative predictive power, conversely, refers to those accurately said to 
not have the condition by that test. For attention-related tests, PPP would related to the 
diagnosis of ADHD; for feigning tests, it would relate to malingering.  Predictive values 
calculated in a study are unique to the base rates of the condition(s) of interest (in this 
case, both ADHD and FGN), and require adjustment for other base rates.  Predictive 
powers from this study can be applied only in the determination of ADHD versus faking, 
and therefore should only be used when a clinical profile is noted.   
Attention Tests:  Because the C-CPT did not demonstrate adequate construct 
validity through the consistent and overall clinical elevation of scales by ADHD 
participants, its predictive power is irrelevant in that determination, and should not be 
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 considered.  For the symptom-report measures, because no guidelines have been 
published to date regarding the detection of ADHD in undergraduate populations where 
feigning may be a factor, the sample-specific sensitivities may likewise have reduced 
construct validity.  It is therefore not recommended that they by used on an individual 
basis in that determination, at this time.  Further research and/or adjustment of cut scores 
is necessary. 
Symptom Validity Tests:  Due to the high specificity of these measures, high 
Positive Predictive Power can be expected such that individuals said to be feigning are 
highly likely to have been accurately classified. Indeed, the mean PPP was .904, and was 
perfect for the DMT (1.0) and lowest for the TOMM T1 (.863).   Because of lower 
sensitivities, however, only moderate negative predictive values can be expected. Not 
surprisingly, at published cutting scores of feigning measures, a mean NPP of .483  was 
observed for the cognitive feigning indices alone.  This was highest for the TOMM T1 
(.866) and lowest for the NV-MSVT Scale A (.636).   As the proportion of malingerers 
falls from the approximately 50% base rate in this sample, NPP will increase and PPP 
will decrease.  
Identifying an Optimal Combination of Predictors 
Binary logistic regression can be used to identify, in an exploratory manner, the 
optimal combination of tests for predicting feigning versus ADHD status.  As previously 
stated, it would be ideal to have a series of measures that first identify ADHD individuals 
with high sensitivity to the disorder, then rule out feigning with high specificity, and then 
identify feigners with high sensitivity to that behavior.  The lack of ADHD-sensitive 
measures in this population precludes that.  Instead, we can only examine the feigning 
measures for the best “predictors.”   
Two logistic regression models were undertaken.  In the first, the predictor  
variables examined were the classification status of “probably feigning” or “probably  
honest,” assigned at the published cut score of each feigning measure.  The second model 
examined instead the continuous, raw test data for those measures examined in Model 1.  
Both models tested the accuracy of classifying individuals as ADHD or FGN-role.  
Model 2 was examined as it is unclear how optimal the published cut scores are for this 
sample of educated, high-functioning individuals.  Because little to no research exists on 
 63  
 the use of this study’s measures in the distinction of ADHD vs. feigning for under-
graduates, the forward conditional method of data entry was used.  Here, all variables are 
made available for entry and  the statistical software identifies the single best predictor, 
and then it identifies subsequent predictors that add significant incremental predictive 
power above the first.  When measures such as the TOMM had multiple indices, the best 
predictor of FGN vs. ADHD status was selected according to AUC values obtained in 
ROC analyses.  These included the TOMM T1 (using a 90% cut score for Model 1), the 
DMT, LMT, MSVT Scale A, and M-FAST.  The WMS-III Inconsistency Index, as it 
does not have a published cut score, could only be evaluated in Model 2. 
Model 1:  Results (depicted in Table 3-12) indicate an overall significant model 
for the dichotomous variables (χ2 (5, N=58) = 31.698, p = .000), in which 86.2% of 
individuals were accurately classified (Nagelkerke R-square = .660).  In Step 1, the 
TOMM T1 was entered as a single best predictor (β = 3.401, SE = .729, p = .000), 
correctly classifying 84.5% of individuals.  The final Step 2 entered the DMT, which 
added incremental predictive power (change p = .010) when applied after the TOMM, 
raising the classification accuracy to its final 86.2%.   However, it must be noted that 
both the LMT and MSVT Scale A were quite comparable to the DMT (change p = .013 
and .026, respectively), so it is not safe to say that this model would hold up when 
retested on another sample. In other words, the LMT or MSVT Scale A may be 
appropriate secondary measures at their published scores. 
Model 2:  Results (depicted in Table 3-13) likewise indicate an overall significant 
model for the raw data (χ2 (6, N=58) = 24.318, p = .000), also correctly classifying 
precisely 86.2% of FGN and ADHD participants (Nagelkerke R-square = .703).  Here, 
however, while Step 1 similarly entered the TOMM T1 (β = -.174, SE = .045, p = .000), 
and Step 2 the DMT (β = -.404, SE = .190, p = .034), a third step was included to add 
incremental predictive accuracy via the M-FAST (change p = .034).   
Understanding Feigning Strategies 
The feigners in this study, simply coached on symptoms, asked not to be too 
obvious, and reminded to do at least as “well” or “similar” as someone who would gain 
admission to a university, reported only mediocre confidence in their performance (M = 
3.3, SD = .80 on a five-point Likert with five being “completely successful”), despite
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 Table 3-12 
 
Binary Logistic Regression Analysis for Predicting FGN vs. ADHD Status from Cognitive and 
Psychiatric Feigning Tests’ Classification as Probably Feigning or Probably Honest 
 
   
95% CI for exp b  
 
β (SE) 
 
Lower exp b Upper 
Classification 
Rate 
      
Step 1      
      
TOMM T1 class 3.401 (.729)*** 7.186 30.000 125.250 84.5% 
      
      
Step 2      
      
TOMM T1 class 3.109 (.804)*** 4.633 22.400 108.298  
      
DMT class 21.076 (10921.517) .000 .000 - 86.2% 
 
Note.  Forward Stepwise Conditional Logistic Regression was used due to the pilot nature of 
these data.  Step One entered the observed classification for the following symptom validity 
measure to predict FGN or ADHD role: TOMM T1, DMT, LMT, NV-MSVT A, M-FAST.   The 
overall model was significant, χ2(5, N=58) = 31.698, p = .000.  The DMT and LMT were very 
similar, p = .010 and .013, respectively.  ***=p < .001; Class = probably honest or probably 
feigning classification according to published cut score; SE = Standard Error; CI = confidence 
Interval.  R2 = .660 (Nagelkerke), .495 (Cox & Snell).  Model Chi-square(5) = 31.698, p < .001.   
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 Table 3-13 
 
Binary Logistic Regression Analysis for Predicting FGN vs. ADHD Status from Cognitive and 
Psychiatric Feigning Test Scores 
 
   
95% CI for exp b  
 
β (SE) 
 
Lower exp b Upper 
Classification 
Rate 
      
Step 1      
      
TOMM T1 pr -.174 (.045)*** .769 .840 .918 79.3% 
      
      
Step 2      
      
TOMM T1 pr -.175 (.055)*** .754 .840 .934  
      
DMT pr -.404 (.190)* .460 .668 .970 84.5% 
      
      
Step 3      
      
TOMM T1 pr -.168 (.056)** .758 .846 .944  
      
DMT pr -.491 (.218)* .400 .612 .938  
      
M-FAST tot .447 (.267) .926 1.563 2.639 86.2% 
 
Note. Forward Stepwise Conditional Logistic Regression was used due to the pilot nature of these 
data.  Step One entered the raw score for the following symptom validity measure to predict FGN 
or ADHD role: TOMM T1, DMT, LMT, NV-MSVT A, M-FAST, and WMS-III Inconsistency 
Index.  M-FAST significance of the change = .034.   The overall model was significant, χ2(6, 
N=58) = 24.318, p = .000.  *** = p < .001, ** = p < .01, *= p < .05; pr = percent correct; tot = 
total score; SE = Standard Error; CI = confidence Interval.  R2 = .703 (Nagelkerke), .527 (Cox & 
Snell).   
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 their success as a group.  Knowledge of how the undergraduate students in this sample 
feigned the disorder when fiscally motivated might be helpful for refining existing and 
creating new detection strategies.   
Self-Reported Feigning Strategies:  Table 3-14 presents the self-reported 
strategies provided by malingering-role students.  Because this was the last question in 
the protocol, few responded with notable detail or took time to thoughtfully respond.  
These are provided for descriptive purposes only as some students listed several 
strategies within multiple categories and others, just a few.  As illustrated in the table, 
students were about equally likely to list strategies involving physical behavior (despite 
being told this was unnecessary), learning style, and response style.  Examples of 
physical strategies including fidgeting, looking around, and responding slowly. Students 
endorsing altering their learning style most often stated that they tried not to concentrate 
or pay attention, such as when learning items to memorize.  With regard to response 
style, a number of students reported deliberately choosing the wrong answer; though 
surprisingly, only a few mentioned endorsing ADHD-like symptoms on the symptom 
report measures.  
Assessment of Feigning Strategy on ADHD-“Diagnostic” Testing:  Feigning 
strategy for these measures is described by the number of symptoms endorsed and the 
specific ADHD subtypes obtained.  The FGN group was exceptionally successful in 
faking the ARS Current and Childhood Symptoms scales.  Figure 1 shows that Current 
specific ADHD subtypes obtained.  The FGN group was exceptionally successful in 
Symptom endorsements resulted in frequencies of Combined, Inattentive, and 
Hyperactive-Impulsive subtype specifications that were virtually identical to those of the 
ADHD group.  These results suggest that a sizable proportion of university students 
avoided the “blanket endorsement” strategy for Current Symptoms (though this was more 
common for Childhood Symptoms, Figure 2), and that students were more likely to view  
the disorder as characterized by inattention than hyperactivity at this age.   
On the CAARS—S:L, FGN participants tended to clinically elevate either 2-3 or 
6-8 subscales, while ADHD participants demonstrated a parabolic incline in the number 
of subscales clinically elevated (0-1, 2-3, 4-5, or 6-8).  This may illustrate two different
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 Table 3-14 
Reported Feigning Strategies 
Frequency 
Strategy / Examples (N = 26) 
  
Reference to physical behavior strategy* 14 
    General reference (e.g., “physical mannerisms” 4 
     Fidget 3 
     Look away / look around, not look at items to memorize 3 
     Be dazed / “daydreamy” / less alert 3 
     Respond [at a] slow [rate] 2 
     Act frustrated /look uncomfortable with easy items 2 
     Make no eye contact 1 
  
Reference to learning strategy 15 
     Not concentrate / pay attention / focus 12 
     Try not to memorize / remember / learn 3 
     Not look at [stimulus items] 3 
     Not pay attention to instructions, specifically 2 
     Ignore details 1 
  
Reference to response strategy 17 
     Indicated deliberate errors 12 
          ?  Made reference to placement or spread of errors  (3) 
          ?  Reference to controlling or reducing number of errors (3) 
          ? Only pick wrong answer when it was close (1) 
     Respond with regard to ADHD symptoms / be dishonest about symptoms 2 
     Respond [at a] slow [rate] 2 
     Guess [between available answers, rather than thinking] 1 
 
Note.  Some students provided responses in multiple categories, or multiple responses within one 
category.  Values in bold Values in parentheses represent components of the above category.   
* = Students were told that they did not need to physically act as if they had ADHD. 
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 feigning strategies.  Because the CAARS—S:L does not lend to subtype identification, 
FGN-ADHD patterns were not examined. 
Omissions (misses), commissions (false positives), perseverations, and hit rate 
(response speed) were examined as potential faking strategies for the C-CPT.  Feigners 
were successful in their use of perseveration and response rate only:  Results reflect that a 
relatively similar proportion of feigners and ADHD participants obtained clinically 
notable levels of perseverations (43.3% for FGN versus 31.0% for ADHD).  Also, the 
proportion of FGN participants achieving altered response rates was equivalent to that of 
the ADHD group (76.7% versus 75.9%).  Of note, those feigners who altered their hit 
rate responded faster than normal in 65.2% of cases; this was true for 68.2% of ADHD 
participants.  FGN-role participants only marginally matched ADHD participants in their 
use of false positive errors (with 73.3%, versus 55.2%, respectively having noteworthy 
numbers of these).  Feigners were least successful with their use of misses (60.0% versus 
31.0% clinically noteworthy).
Copyright © Myriam J. Sollman 2008 
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 Chapter Four:  Discussion 
 A number of motivators exist at the university level for students to seek diagnosis 
of ADHD, regardless of whether or not they truly believe they have the disorder.  While 
research shows that symptoms of ADHD may remit with age (Shaw, 2002; Farone, 
Biederman, & Mick, 2006; Biederman et al., 1996), and that impaired students may have 
difficulty advancing to higher education (see Barkley & Murphy, 2006) evidence 
explored earlier also suggests that there has been a disproportionate increase in ADHD-
based claims in higher education in recent years. Unfortunately, little research exists on 
how to separate genuine from feigned ADHD symptoms presented by an educated young 
adult population.  Results from studies on malingering in neurocognitive impairment 
groups cannot automatically be expected to generalize to these individuals.   
 This study evaluated the efficacy of various attention-related, neuropsychological, 
and symptom validity measures in the detection of feigned ADHD in an undergraduate 
sample.  Performance was compared between a group of presumed normal students 
(HON), a group of diagnostically “clean” ADHD students asked to respond to the best of 
their ability (ADHD), and a group of motivated, coached feigners (FGN).  Feigners were 
educated about symptoms and characteristics of ADHD, provided with a scenario to help 
them relate to the plight of a student would might seek diagnosis, asked not to fake too 
obviously (by  performing at least as well as a college student would), and provided with 
a significant monetary incentive for “successful feigning” ($45).  They were not 
forewarned about the specific types of tests they would take, nor alerted to the presence 
of malingering detection instruments. 
This study provides novel results, as little research exists on the susceptibility of 
attention-related, neuropsychological, and symptom validity measures to feigned ADHD 
in undergraduate samples.  Because of the higher cognitive ability of college students and 
the poorly understood difficulties posed by ADHD undergraduates, it could not be 
assumed that all of these measures would be appropriate.  Not surprisingly, results 
illustrated that the ADHD symptom-report measures, though sensitive to ADHD, were 
quite susceptible to faking.  The ARS was successfully faked in 80% of cases (according 
to the 1996 norms) and the CAARS—S:L in 67% of cases (when using a stringent cut 
score of 4 or more clinical scale elevations). Students did not take a blanket feigning 
 72  
 strategy by endorsing all symptoms on the measures; instead, the proportion of 
individuals achieving Combined subtype, Inattentive Subtype, and Hyperactive Subtypes 
closely matched that of the ADHD group.  The Conners CPT, in contrast to those 
measures, had both limited sensitivity to ADHD and specificity for FGN in this sample.  
Only about 24% of ADHD students were consistently identified by published cut scores, 
and slightly less than 50% of FGN-role participants obtained clinically elevated results.  
A selection of neuropsychological tools validated to assess attention, 
concentration, memory, and reading speed, including the Stroop task (Golden & 
Freshwater, 1999), Nelson-Denney Comprehension Test Reading Speed component, and 
the WMS-III Word Lists subscale, likewise had limited utility in separating ADHD from 
HON groups.  Evidence from these measures suggests that the admonished feigners 
obtained only slightly depressed scores, but enough so that their performance as a group 
was worse than that of the HON group.  Only the Stroop Word subscale had FGN-ADHD 
differences, and the measures generally did not have HON-ADHD differences due to 
comparable reading speeds and list learning abilities.  Thus, the chosen battery of 
neuropsychological measures may have limited utility in the identification of genuine 
ADHD symptoms and feigned presentations.   
At their published cutting scores, several neurocognitive feigning measures 
demonstrated strong specificity, with large AUCs illustrating good classification at the 
range of cutting scores.  ADHD participants were very unlikely to be misclassified as 
feigners by these measures, so when applied to clinical evaluations of like samples, 
reasonable accuracy might be expected for those who were identified as feigners.  The 
TOMM Trial 1 demonstrated the highest sensitivity, and was the only measure with 
adequate sensitivity to detect feigning at cutting scores employed.  However, its 
corresponding specificity was below 90%.  Moreover, this index has only infrequently 
been recommended for use in screening for feigning (see Sarmra, 2004; Bauer, O’Bryant, 
Lynch, McCaffrey, & Fisher, 2007; O’Bryant, Engel, Kleiner, Vasterling, & Black, 2007; 
Gavett, O’Bryant, Fisher, & McCaffrey, 2005).  In the present study, binary logistic 
regression using various feigning test results (Honest or Probable Feigning) identified the 
TOMM T1 followed by the DMT as strong predictors in combination.  The LMT and  
M-FAST demonstrated incremental predictive ability closely matching the DMT in the  
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 present sample.   
 It was hoped that a three-step classification procedure, where ADHD is identified  
with a highly sensitive test (or series of measures) in the first step,  feigning is ruled out 
with a highly specific symptom validity tool in the second step, and probable feigning is 
identified with more sensitive malingering tests in the third step, would be identified.  
However, such did not emerge from these data.  At this time, it is necessary to be reliant 
on clinicians’ use of sound diagnostic procedures to arrive at a confident “pre-diagnosis” 
of ADHD.  These include a detailed clinical interview, corroborating interview (for  
historical information and evidence of dysfunction), neuropsychological and 
psychological testing (to rule out all alternate cognitive and psychiatric conditions), and 
an evaluation of possible incentives for feigning.  Fortunately, the present data indicate 
that there exist at least two strong, easily administered measures—the TOMM and the 
DMT—against which the classification accuracy of a pre-diagnosis of ADHD can be 
assessed relative to feigning.   
 Two major limitations exist in this study: the first lies in the nature of the research 
design, the second, in the nature of the clinical group.  As both a pilot study and a 
simulation design, generalizability of the data is limited, and cross-validation in multiple 
university or college settings and geographical regions is necessary.  Because no “gold 
standard” exists to identify either genuine ADHD or feigned ADHD in this population, 
researchers must rely on the analog methodology at this time.   
Regarding the clinical sample used, a few points must be noted.  First,  diagnostic 
accuracy of the ADHD group could not feasibly be perfect. Clinicians undoubtedly vary 
in their approach to diagnosing the disorder, as well as the base rate at which they apply 
it.  To assess the likelihood that each student’s diagnosis was accurate,  ADHD 
participants were phoned 3-15 months after their participation.  Each was told that “some 
psychologists or psychiatrists may diagnose the disorder when they are not 100% certain 
the individual has it, as many conditions share symptoms with ADHD,” and then asked to 
rate the confidence they had that the diagnosis pertained to them on a scale of 1 to 10, 
with 10 being absolutely confident.  Nineteen students were reached, but one provided a 
rating of “five, chance” because he believed that “ADHD is a made-up condition.”  This 
student’s results were excluded.  The remaining had a mean rating of 9.2 (SD = 1.00), 
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 reflecting high certainty that they had ADHD, and not another condition with similar 
symptoms.  Anecdotally, the data of two students who provided responses of complete 
certainty had been excluded from analysis for failure to produce clinical profiles on the 
ADHD-specific tests. 
 Another concern regarding the clinical group is that performance was obtained  
from ADHD students without known comorbid diagnoses.  Though this may have 
increased diagnostic certainty to some extent, application of these results to students with 
greater pathology should not be assumed until more data are available.  In addition, 
substance use of the ADHD group was not evaluated to rule out the influence of this on 
symptoms reported.  Second, and related, without independent evaluation of the ADHD 
condition for each participant before inclusion, the clinical standing of each participant 
cannot be verified.  Accuracy was maximized by ruling out participants with comorbid 
diagnoses and omitting those students who failed to present current symptoms of ADHD 
(N = 4).  
Additional research is needed in this field in order to identify measures or to re-
calibrate scoring methods in order to accurately identify ADHD as disordered university 
undergraduates experience it.  Evidence suggests that adults seeking first diagnosis, and 
adults who were diagnosed during childhood, experience ADHD differently than children 
do (see Barkley, Murphy, & Fischer, 2008).   Moreover, further research is necessary to 
identify procedures that rule out suboptimal effort and altered self-presentation, within 
the young adult population.  Evaluations should not be limited to the measures explored 
in this study.   With more research, adjustment of cutting scores in existing measures may 
prove useful.  A focus on maximizing specificity for “honesty”  before then identifying 
measures sensitive to feigning, is recommended.  Comparing the forced-choice methods 
employed in this study, it appears that both face validity and actual difficulty may have 
played a role in the accuracy of these measures, particularly the LMT and DMT.  It will 
be necessary to obtain further information on the performance of the most successful 
index in this population—TOMM Trial 1—as well as to develop additional measures to 
maintain the advantage over bright, motivated students.  
Copyright © Myriam J. Sollman 2008 
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 Appendix A.  Mass Screening Form. 
 
                                                                                         Student ID: __ __ __ __ __ 
 
 
 
Some research opportunities are available for individuals who have been diagnosed with,  
or without, certain disorders.   
 
 
Do you presently have a diagnosis of: 
 
ADD or ADHD     Yes / No 
An anxiety disorder    Yes / No 
A depressive disorder    Yes / No 
A thought disorder    Yes / No 
A learning disability    Yes / No 
 
Have you ever been knocked unconscious? Yes / No 
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 Appendix B.   Clinical Participant Recruitment Flier 
Attention UK Undergraduates: 
 
Do you have  
Attention Deficit Disorder? 
(ADD or ADHD) 
 
 
If so, you can make $45  
by participating in a research study.   
 
We would like to see how effective  
various tests are at diagnosing ADHD  
in college students. 
 
please call for more information:   
Myriam 
 (859) XXX-XXXX  
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 Appendix C.   Phone Screening Form for Non-Clinical Undergraduates 
 
SAY:  My name is __ and I'm calling from the Department of Psychology.   I'm contacting you because 
you completed the Introductory Psychology mass screening session and indicated interest in a research 
study for Introductory Psychology research credits.  I have a 2-credit study.  Do you still need research 
credits at this time?  (if Yes):  Great!  I'd like to tell you more about the study, but first I  need to get some 
general information to see 
 if you qualify. Only your first name and phone number will be associated with the information you provide, 
if  
you tell me at the end of this call that you are still interested.  Ok? 
 
1.  How old are you?____________________________ 
 
2.  What year are you?  F So Jr Sr Other: (_____ th    semester) 
 
3.  What is your first language: ___________________ 
 
4.  This is a study about ADHD.  We have openings for people with and without ADHD.  Have you been 
 diagnosed with ADHD?   Yes  No 
If yes, complete ADHD Group phone screening tool. 
 
5.  We also have openings for people with and without an anxiety disorder.  Have you been diagnosed with 
an anxiety disorder?  Yes  No   
 
6.  How about a learning disability? Yes  No 
 
7.  Have you been diagnosed with any other psychological, psychiatric, or neurological disorders?  
 _______________________________________________________________________   
 
SAY:  Thank you very much for answering these questions.  Now let me tell you more about the study.  This  
study involves you taking a number of different tests that are used to diagnose ADHD.  We are interested in  
whether these  tests can discriminate between people with ADHD people without its.  The tests are all 
pencil / 
paper, verbal, or computerized.  If you participate, it will take about two hours of your time and you will be 
compensated 2 research credits. 
 
Are you still  interested in participating? 
If yes: collect contact info   If No: stop (circle)   
 
8.  First name__________________ Phone_________________ 9.  Gender: M
 F 
 
Thank you.  I will give this information to the lead investigator in charge of this study and she will contact 
you within one month to schedule an appointment if you meet criteria. 
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 Appendix D.  Phone Screening Form for ADHD Participants. 
 
SAY:  Hi.  My name is Myriam Sollman and I'm calling from the Department of Psychology regarding an 
ADHD research study.   
THEN EITHER: 
-I received your message about participating in the study.  Thank you for calling!   
-I'm calling because you completed the Introductory Psychology Mass Screening Questionnaire and 
indicated an interested in participating in research studies.  I have a 2-credit study.  Do you still need 
credits?  [If yes]:  Great!   Thank you for your interest in this study.   
THEN: 
I need about 5 minutes of your time to tell you a little about the study, and ask some questions to see if you 
qualify for this study. Is this a good time for you? 
THEN:  
This is a study about the ability of some tests to properly diagnose people who do or do not have ADHD.  If 
you qualify and are interested in participating, it takes about 2 hours and pays $45 [if applicable, as well 
as 2 Intro Psyc research credits].  I need to ask you some more questions, some of which may seem 
personal.  However, only your first name and phone number will be associated with the answers if at the 
end of this call you state that you are interested in participating.  Also, only I, a PhD student in the 
Department of Psychology, will have access to your responses. 
 
1.  Where did you see this ad?_____________________ 
 
2.  How old are you?____________ 3.  Are you a UK student?_________________ 
 
4.  What year?  F So Jr Sr Other: (_____ th    semester) 
 
5.  What is your first language?___________________ 
 
6.  As you know, this is a study about ADHD.  We have openings for people with and without ADHD.  
Have you been diagnosed with ADHD?   Yes  No 
 
If No, collect contact info and tell individual that we will call them to schedule if they meet criteria.  If 
Yes, continue…. 
 
7.  I'd like to ask you more about that.   
a.  When were you diagnosed (age/grade/year?)_____________________________________ 
b.  What sort of health care professional gave you this diagnosis?   
GP   psychiatrist    psychologist    neuropsychologist    
DK 
or PhD  MD 
 
8.  Now I'd like to ask you about the process you went through to get diagnosed. 
a.  Did you take any tests?       Yes No 
 (If yes): What sorts of tests 
 __ pencil / paper that asked about your symptoms 
 __ pencil / paper not asking specifically about symptoms 
 __ Computerized 
 b.  Did your parent or guardian fill out any questionnaires?   Yes No 
 c.  Do you remember how long this evaluation took?  Was it one appointment, more?
 _________________________________________________________________________ 
 
c. Was there someone who came into the classroom to observe you?  Yes  No 
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 Appendix D cont. 
 
 
9. Do you have access to a diagnostic report or evaluation?     Yes
 No   
 
10.  Are you taking medication for this right now?       Yes
 No 
  (If yes): ____________________ 
 
11.  About how often do you skip a dose, either accidentally or on purpose? _________________ 
 
12.  We have different opportunities for people in this study.  One involves not taking medication for about 
12 hours before your participation, so that we can know how people with ADHD do without treatment.  
Would you be interested in doing this?  I would work around your school schedule, and can test on a 
Saturday if you prefer.          
  Yes No  
 
13.  Another opportunity is for people who have been diagnosed with other disorders.  Do you currently 
have a diagnosis of a learning disability?       
 Yes No 
 
14.  How about any mood, anxiety, or thought disorder?     Yes
 No 
 
14.  How about any other psychiatric, psychological, or neurological disorder?   Yes
 No 
 
SAY:  Thank you for answering these questions.  Now let me tell you more about the study.  This study 
involves you taking a number of different tests that are used to diagnose ADHD.  Some of them, you may 
have taken before.  These are all pencil / paper, or computerized tests.  If you qualify and participate, it 
will take about two hours of your time and you will be compensated $45.  The study is conducted at Kastle 
Hall on UK's campus.   
 
If you qualify for enrollment, would you like to participate? 
 
If Yes:      If No: Stop  (circle no) 
 
14.  First name__________________  Phone_____________________ 
 
15.  Gender: M F 
 
 
Thank you.  I will have to determine if you meet criteria.  If you do, I will call you to schedule your 
appointment within the next month. 
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 Appendix E.  Demographic Questionnaire 
 
INSTRUCTIONS:  Please respond to the following as best you can.  You do not need to share your 
responses with the examiner.  Your responses will NOT be associated with your name.  Please put this in 
the envelope and seal it when done. 
 
Gender:   M     F   
 
Age: _______________   
 
Handedness:     R     L  
 
Ethnic background:     
African American  Hispanic/Latino       Native American 
Asian/Pacific Islander           Caucasian            Other______________________ 
 
Education: Freshman      Sophomore     Junior      Senior       Other _________________________ 
 
Please check which apply to you.  If you respond "Yes," please answer the Additional questions below: 
 
1. Color Blindness        N     Y    
 
2. Repeated a Grade   N     Y  
 
3. Knocked Unconscious       N     Y   
 
 (respond for most severe occurrence) 
Length of Time:  Unconscious________      Hospitalized_________ 
 Age of occurrence: _________  Do you remember this happening?_______ 
 
4. Attention Deficit Disorder  N     Y  
 
Type: ___________________________  Age diagnosed:________ 
 What medication do you take for this?__________________________ 
 Have you taken medication for this in the past 12 hours?      Y / N 
 
5. Learning Disability      N     Y  
   
Type: _____________________  Age diagnosed:________ 
 
6. Current Mood, Anxiety,  N     Y     or Thought Disorder   
(list separately)  
Type: ____________________   Age diagnosed:___   Are you currently being treated?  Y / N 
Type: ____________________   Age diagnosed:___   Are you currently being treated?  Y / N 
Type: ____________________   Age diagnosed:___   Are you currently being treated?  Y / N 
 
7.  Neurological or Neuro-     N     Y      degenerative Disorder   
(list separately)  
Type: ___________________    Age diagnosed:___    Are you currently being treated?  Y /N 
Type: ___________________    Age diagnosed:___    Are you currently being treated?  Y /N 
    
Thank you!  Please seal this in the envelope provided. 
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 Appendix F.  Packet Given to Faking Group  
 
Faking ADHD 
 
While faking ADHD, it may help you to pretend that this scenario applies to you:   
 
Your roommate has been diagnosed with ADHD.  S/he had trouble with classes, but then  
was given some medication for ADHD, and now does well.  S/he even got a couple of  
A's recently, and has more time to socialize because studying is not as hard!  During  
your midterms, you decided to try your roommate's medication, and ended up surprising  
yourself with how much easier things went.  You may think that you have undiagnosed  
ADHD, so you "Google" the disorder to learn more about it.  On the following pages are 
some of the things that you find.   
 
Feel free to underline or write notes on these pages.  At the end of the internet information, 
you will be asked to jot down a few symptoms or characteristics of people with ADHD to 
help you fake. 
 
Website 1 
Address http://www.daytrana.com/?SOURCE=GOOG&KEYWORD=p 
 
WHAT ARE THE SYMPTOMS OF ADHD? 
• The most common behaviors exhibited by those who have ADHD are inattention, 
hyperactivity, and impulsivity. People with ADHD often have difficulty focusing, are    
easily distracted, have trouble staying still, and frequently are unable to control their 
impulsive behavior.  
• Because everyone shows signs of these behaviors at times, the DSM-IV-TR specifies that  
the behaviors must appear early in life (before age 7) and continue for at least six months. 
• In children, these behaviors must be more frequent or severe than in other children the    
same age. In addition, the behaviors must interfere with at least two areas of a person’s     
life, such as paying attention in school, completing homework, or making friends.  
• ADHD in adults looks much as it does in children, except that much less hyperactivity is 
present. Still, inattention and impulsivity can have a major effect on functioning at work   
and in social relationships.  People often have difficulty focusing, are easily distracted,    
have trouble staying still, and frequently are unable to control their impulsive behavior.  
1
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Website 2 
Address http://www.adultADHD.com/2_2_recognizing/2_2_recognizing.jsp 
 
Recognizing Adult ADHD 
Fidgeting, interrupting conversations, losing things, forgetting the reason for a trip             
to  the grocery store – everyone acts this way once in a while. But a long and persistent   
history of restless, impulsive, or inattentive behavior may be a sign of Adult ADHD.      
This is especially true if these behaviors have existed since childhood and result in 
problems at work, home, and/or in social situations. 
If you think you may have Adult ADHD, here are several questions you may want to       
ask yourself. These are some of the questions that can help doctors and healthcare 
professionals screen for Adult ADHD. 
Ask yourself these questions and think about how long you have experienced these 
symptoms and how often they occur. If these symptoms are interfering with your      
success at home, at work or with friends, you may want to talk with your doctor or 
healthcare professional about a clinical evaluation. 
• Do you have difficulty concentrating or focusing your attention on one thing? 
• Do you often start multiple projects at the same time, but rarely finish them? 
• Do you have trouble with organization? 
• Do you procrastinate on projects that take a lot of attention to detail? 
• Do you have problems remembering appointments or obligations? 
• Do you have trouble staying seated during meetings or other activities? 
• Are you restless or fidgety? 
• Do you often lose or misplace things? 
2
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Research Participant:  On the next two pages are diagnostic screening tests you find.  Please read 
through the questions.  You do not need to complete the tests. 
 
Website 3 
Address http://www.adultADHD.com/2_2_recognizing/2_2_recognizing.jsp 
 
Screener Test 
Many adults have been living with Adult Attention-Deficit Disorder (Adult ADHD) and  
don't recognize it. Why? Because its symptoms are often mistaken for a stressful life. If 
you've felt    this type of frustration most of your life, you may have Adult ADHD; a 
condition your doctor   can help diagnose and treat. 
 
Adult Self-Report Scale (ASRS – V1.1) Screener  
      from WHO Composite International Diagnostic Interview 
© World Health Organization
  
 
 
How often do you have trouble wrapping up the final details of a            
project, once the challenging parts have been done? 
◘   ◘   ◘   ◘    ◘ 
V
er
y 
O
fte
n 
So
m
et
im
es
 
R
ar
el
y 
N
ev
er
 
O
fte
n 
  
How often do you have difficulty getting things in order when  ◘   ◘   ◘   ◘    ◘ 
you have to do a task that requires organization?  
  
How often do you have problems remembering appointments ◘   ◘   ◘   ◘    ◘ 
or obligations?   
  
When you have a task that requires a lot of thought, how  ◘   ◘   ◘   ◘    ◘ 
often do you avoid or delay getting started? 
  
How often do you fidget or squirm with your hands or  ◘   ◘   ◘   ◘    ◘ 
your feet when you have to sit down for a long time? 
  
How often do you feel overly active and compelled to do things,  
◘   ◘   ◘   ◘    ◘ like you were driven by a motor?   
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Website 4 
 
Address http://psychcentral.com/ADHDquiz.htm 
 
Adult ADD/ADHD Test 
Jasper/Goldberg Adult ADHD Screening Quiz 
by Larry Jasper & Ivan Goldberg  
Instructions: The 24 items below refer to how you have behaved and felt DURING MOST OF 
YOUR ADULT LIFE. If you have usually been one way and recently have changed,  your 
responses should reflect HOW YOU HAVE USUALLY BEEN. For each item, indicate  the 
extent to which it is true by checking the appropriate box next to the item.  
 
1. At home, work, or school, I find my mind wandering from tasks that are uninteresting or     
     difficult.  
2. I find it difficult to read written material unless it is very interesting or very easy.  
3. Especially in groups, I find it hard to stay focused on what is being said in conversations.  
4. I have a quick temper... a short fuse.  
5. I am irritable, and get upset by minor annoyances.  
6. I say things without thinking, and later regret having said them.  
7. I make quick decisions without thinking enough about their possible bad results.  
8. My relationships with people are made difficult by my tendency to talk first and think later.  
9. My moods have highs and lows.  
10. I have trouble planning in what order to do a series of tasks or activities.  
11. I easily become upset.  
12. I seem to be thin skinned and many things upset me.  
13. I almost always am on the go.  
14. I am more comfortable when moving than when sitting still.  
15. In conversations, I start to answer questions before the questions have been fully asked.  
16. I usually work on more than one project at a time, and fail to finish many of them.  
17. There is a lot of "static" or "chatter" in my head.  
18. Even when sitting quietly, I am usually moving my hands or feet.  
19. In group activities it is hard for me to wait my turn.  
20. My mind gets so cluttered that it is hard for it to function.  
21. My thoughts bounce around as if my mind is a pinball machine.  
22. My brain feels as if it is a television set with all the channels going at once.  
23. I am unable to stop daydreaming.  
24. I am distressed by the disorganized way my brain works.  
 
 
Research participant: When you are done reviewing these materials, please use the colored 
paper to jot down symptoms that will help you remember how to fake on the tests you will be 
given. Tell the examiner when you are done. 
 
 
 
4
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Debriefing Form:  Faking Group 
 
Thank you for participating in our study!  As we told you in the beginning, the purpose of this 
study is to determine how effectively some tests discriminate between individuals with true  
ADHD and individuals asked to fake ADHD.  
 
In order to motivate you to fulfill your role as well as you could, we offered that you would 
receive a "bonus incentive" if you followed instructions and were successful in your role.  In 
reality, everyone is given this incentive.   
 
We ask that you do not discuss this with anyone.  If others know how the study is run, then we 
will not get the effort and motivation from participants necessary for us to determine if these  
tests really work!  This is an important study that can bring the University of Kentucky much 
recognition if it is run properly, so please do not discuss what you did with anyone! 
 
If you do not wish to have your data included, please tell the examiner now. 
 
Thank you again for your participation! 
 
 
 
 
I   MAINTAIN CONSENT / WITHDRAW CONSENT  to have my data used in this study. 
                   (circle one) 
 
 
 
______________________________            _____________________________ 
Print Name  Date             Witness   Date 
 
_____________________________            ______________________________ 
Sign Name  
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Post-Testing Questionnaire 
 
Please write the instructions (role) you were given at the very beginning of this study:  
 
 
 
 
 
 
 
How well did you understand these instructions given at the very beginning? 
 
___________________________________________________________ 
1  2  3  4  5 
Not at               Perfectly   
All                  Well 
 
 
 
 
 
How hard did you try to follow the instructions or role given at the very beginning? 
___________________________________________________________ 
1  2  3  4  5 
Not at                   Your  
All                 Hardest   
        
 
 
 
How successful do you think you were at following those instructions or playing the role 
given at the very beginning? 
___________________________________________________________ 
1  2  3  4  5 
Not at           Somewhat         Extremely   
All          Successful         Successful 
 
 
 
What was your strategy for this? 
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